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ABSTRACT 
Respiration is the process by which an organism utilizes the reducing equivalents (electrons) 
produced during catabolism to create an electrochemical potential across the cellular membrane, 
which can then be expended to produce ATP. Living organisms, bacteria and archaea in particular 
have discovered numerous ways to respire using highly conserved enzyme superfamilies whose 
members can couple the free energy released during redox reactions to the creation of proton 
motive force. Combined with biochemical studies, the evolution of these superfamilies deduced 
from bioinformatics is very informative about the structural and functional features that are most 
useful to conserve energy by the creation of proton motive force. This work investigates two 
important enzyme superfamilies whose members are responsible for virtually all aerobic 
respiration on the planet– the bd-type oxygen reductase superfamily and the heme-copper 
oxidoreductase superfamily. 
The bd-type oxygen reductases are present in bacteria and archaea and catalyze the 4-electron 
reduction of oxygen to water. Electrons from membrane bound quinols first reduce a low spin 
heme b from which they are transferred to a di-heme active site where where oxygen is reduced to 
water. Energy is conserved by the transfer of protons from the cytoplasm to the active site which 
is located near the periplasmic surface. E. coli has two bd-type quinol oxidases, called cytochrome 
bd-I and cytochrome bd-II. It had previously been shown that cytochrome bd-I generates a proton 
motive force, but work from another group claimed that this was not the case for bd-II.  As part of 
this work, it was demonstrated that bd-II functions identically to bd-I and generates a membrane 
voltage.   
In a second project dealing with the cytochrome bd superfamily, genomic sequence analysis of 
cytochrome bd revealed a subfamily of distinct enzymes present in archaea. One of these archael 
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cytochrome bds, was heterologously expressed in Escherichia coli, purified and characterized. 
This enzyme was shown to have three hemes b instead of two hemes b and one heme d, as is typical 
of enzymes of this superfamily. The enzyme is highly active, using ubiquinol as substrate.  This is 
the first example in which a member of the cytochrome bd superfamily lacking heme d has been 
isolated and characterized. A third project involving the importance of a glutamic acid residue in 
the active site of Escherichia coli cytochrome bd has also been discussed. 
The heme-copper oxidoreductase (HCO) superfamily contains many proton pumping oxygen 
reductases as well as several subfamilies of nitric oxide reductases (NORs) which convert nitric 
oxide to nitrous oxide. These NORs perform different chemistry than the HCOs but have a very 
similar protein structure and a similar active site. Significantly, the active site of purified NORs 
contain a Fe atom instead of the copper in the oxygen redutases. Using bioinformatics methods, a 
distinct new clade of NORs was identified that was previously not recognized. These enzymes 
have been assumed reduce nitric oxide and were thus named eNORs. One member of this clade is 
encoded in the genome of Rhodothermus marinus, a thermophilic bacteroidete.  
Rhodothermus marinus was shown to possess a nitric oxide reductase by measuring the 
accumulation of nitrous oxide in the containers in which the bacteria is grown on nitrate. Then the 
enzyme was purified and characterized and confirmed to be a nitric oxide reductase.  This confirms 
for the first time a large group of enzymes, previously not identified, that participate in 
denitrification in many prokaryotes. 
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Chapter 1: Introduction 
Respiration is the process by which an organism uses reducing equivalents (electrons) 
produced during catabolism to create an electrochemical potential across its cellular membrane, 
which can then be expended to produce ATP or used for solute/ion exchange or ATP-driven 
pumps. Aerobic respiration refers to the use of oxygen as the terminal electron acceptor in the 
process of energy conservation. The ability to respire oxygen is very advantageous as the free 
energy available in the reduction of oxygen is high. (Figure 1.1) 
 
Figure 1.1 An electron tower adapted from data available in (1). The high reduction potential 
of oxygen makes aerobic respiration energetically favorable. 
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However, molecular oxygen exists in triplet state, i.e. it contains two unpaired electrons of 
parallel spin in its outer orbital. This means that it can only be reduced by one electron at a time. 
This results in the formation of reduced oxygen species which are extremely reactive and have an 
even higher reduction potential than oxygen itself. These reactive oxygen species (ROS) have the 
ability to damage biomolecules and cofactors in enzymes. (2) It is therefore essential that oxygen 
be completely reduced to water without the release of intermediate, toxic reduced oxygen species. 
Living organisms have therefore developed three highly specialized enzyme superfamilies that are 
capable of catalyzing oxygen reduction to water – heme-copper oxygen reductases (HCO), bd-
type oxygen reductases and alternative oxidases (AOX).  
All three of these enzymes have the ability to reduce oxygen to water without releasing 
ROS but, they differ in their ability to harness the energy available in oxygen reduction to generate 
proton-motive force. (3-5) Some of the Heme-copper oxygen reductases are responsible for the 
most ATP generation/ O2 reduced, while the bd-type enzymes generate less electrochemical 
potential and alternative oxidases do not contribute to the generation of proton-motive force at all. 
(6-9) Within the physiological context, each of these enzymes play diverse roles in respiration, 
oxygen detoxification, redox control, prevention of formation of ROS etc. 
With regards to aerobic respiration, this thesis deals only with the mechanism of oxygen 
reduction, energetic efficiency, distribution and role of bd-type oxygen reductases. The role of 
heme-copper oxygen reductase family members in denitrification is discussed later. 
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1.1 Cytochrome bd-type oxygen reductase superfamily 
Cytochrome bd-type oxygen reductase  
Cytochrome bd-type oxygen reductase is a respiratory enzyme that reduces oxygen to water using 
electrons extracted from membrane-bound quinols. Cytochrome bd is a transmembrane protein 
consisting of mostly two or sometimes three subunits. (Figure 1.2) (10-12) The enzyme extracts 
electrons from quinol at a quinol binding site using a low spin heme b, named heme b558 based on 
its absorption maxima. (13, 14) These electrons are then transferred to a di-heme active site 
consisting of heme b595 and heme d where oxygen is reduced to water. (Figure 1.2) (15-19) The d-
type heme is a chlorin which is a reduced form of heme b, a protoporphyrin. (20) (Figure 1.3) 
  
Figure 1.2 Crystal structure of cytochrome bd-type oxygen reductase from Geobacillus 
thermodenitrificans. (unpublished data; personal communication from Schara Safarian)  
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Figure 1.3 Molecular structures of heme b and d 
 
Both the quinol binding site and the oxygen reduction site are close to the periplasm. It is 
believed that the protons from quinol reduction are released to the periplasm while the protons for 
the formation of water are obtained from the cytoplasm, using a conserved proton channel. This 
vectorial transfer of charges across the membrane is said to be responsible for the observed 
generation of membrane potential by cytochrome bd. (21, 22) Much of the mechanism of 
cytochrome bd was deduced using indirect biochemical and biophysical assays and our ability to 
further elucidate the catalytic mechanism was severely limited by the lack of a crystal structure or 
similar structural information. Fortunately, our collaborators at Dr. Hartmut Michel’s lab in the 
Max Planck Institute at Frankfurt have recently solved the crystal structure of cytochrome bd to 
an average resolution of ~3.5A (unpublished data) and this information has informed some of my 
later experiments. 
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Distribution and Role of cytochrome bd-type oxygen reductases 
Cytochrome bd-type oxygen reductases are found only in bacteria and archaea. They are 
widely conserved in proteobacteria, firmicutes, cyanobacteria, actinobacteria and bacteroidetes, 
(23) Heme-copper oxygen reductases conserve more energy than bd-type oxygen reductase (6, 24) 
and since they are both encoded in the genome of many organisms, it begs the question – why 
would the organism prefer to use bd if it does not conserve as much energy? It appears that the 
preferential use of one oxygen reductase over the other is most often regulated based on the oxygen 
concentration in the environment. (25) Cytochrome bd and the C-family heme-copper oxidase 
have high oxygen affinity and low energetic efficiency while the A and B family heme-copper 
oxygen reductases have lower affinity for oxygen and translocate more protons per oxygen turned 
over. Nevertheless, bd oxidases play a pivotal role in some bacterial and archaeal electron transport 
chains, particularly where bd is the only respiratory oxygen reductase. (26-31) They have also 
been associated with heme biosynthesis by contributing to the generation of proton motive force 
and protein folding by re-oxidation of DsbB. (32, 33)  
Surprisingly, cytochrome bd is present in the genomes of many ‘strict’ anaerobes. Its 
remarkably high affinity (0.3-0.5 µM) for oxygen (34-36), it was hypothesized, allows these 
organisms to adapt to microaerobic environments by scavenging oxygen using bd. (29, 37-40) This 
is achieved by regulating the expression of bd by Fnr, an oxygen sensitive regulator and ArcAB, 
which is sensitive to the redox state of quinones in the membrane and is activated under 
microaerobic conditions. Fnr represses the expression of the oxidases in the absence of oxygen. 
(25, 37, 41) 
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The oxygen scavenging ability of bd is particularly useful in diazotrophs for protecting 
enzymes sensitive to oxygen exposure like the Molybdenum containing nitrogenase. In Klebsiella 
pneumoniae and Azotobacter vinelandii, cytochrome bd was shown to be essential for nitrogen 
fixing. In Azorhizobium caulinodans, both bd and the C-family heme-copper oxygen reductase are 
both shown to be important for oxygen scavenging. (42-44) 
Bd has also been judged to be part of the oxidative stress response in bacteria because of its 
ability to use up oxygen faster than it can bind to flavins and iron-sulfur cluster proteins, which 
would create ROS. In a recent paper, Imlay et al. suggest that cytochrome bd is maintained in 
anaerobic bacteria particularly to draw electrons and oxygen away from fumarate reductase, a 
prominent culprit in the production of ROS by low-potential redox centers in anaerobic bacteria. 
(2, 45) Furthermore, cytochrome bd was demonstrated to have low peroxidase and significant 
catalase activity. (46, 47) The catalase activity of bd could detoxify H2O2. This might explain the 
peroxide sensitivity of E.coli and Azotobacter vinelandii bd mutants and the enhanced resistance 
to peroxide in mycobacterium when bd is overexpressed. (48, 49) 
Bd is found in many pathogenic and commensal bacteria including Group B Streptococcus, 
Bacteroides, Chlamydia and gram-negative proteobacteria, (26, 29, 30) It was shown to be 
essential during the process of colonization of the host environment as well as for the survival of 
some bacteria during its dormant phase in the host. (35, 50, 51) Interestingly, lactic acid bacteria 
(LAB) and some other bacteria, which do not produce heme use bd in a respiratory chain that 
becomes active in the presence of exogenous heme and quinone. (26, 27, 30, 52) It appears from 
the above evidence, that bd is particularly important for pathogens. Additionally, it is not 
homologous to any human protein and for these reasons, bd has been suggested as a possible drug 
target for treating bacterial infections. (23, 53) 
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In addition to oxidative stress, bd has been associated with response to phosphate starvation 
and acidic environments and other stress conditions. (54, 55) In E. coli and many other organisms, 
multiple copies of bd exist and are regulated under different conditions. It was suggested that the 
different copies of bd differed in their ability to generate proton motive force. (54) This theory has 
been addressed and disproved as part of my dissertation research. (56) 
Most of the above evidence about the function of bd-type oxygen reductases is relevant in 
bacteria. However, genes encoding bd-type oxygen reductases are widely distributed in archaea 
and this thesis attempts to begin an investigation into the characteristics of a bd-type oxygen 
reductase from archaea.  
 
 
1.2 Heme-copper oxygen reductase superfamily of enzymes 
Heme-copper oxygen reductases 
Heme-copper oxygen reductases are multi-subunit transmembrane proteins, which are named 
for the heme and CuB that form a binuclear active site at which oxygen is reduced to water. The 
electrons for oxygen reduction are obtained from membrane bound quinols or cytochrome c; the 
enzymes are accordingly called the quinol oxidase or cytochrome c oxidase respectively. The 
electrons from the electron donor pass from a conserved binding site, through a low spin heme to 
the binuclear site where oxygen reduction happens. (57-59) (Figure 1.4) The active site includes a 
unique cross-linked Histidine-Tyrosine co-factor formed by a ligand to the CuB and a nearby 
Tyrosine residue. This novel co-factor is important for the rapid turnover of oxygen to water, which 
prevents the formation of ROS. (60) 
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Figure 1.4 Crystal structure of A-family cytochrome c oxidase. Figure made using VMD 
(1AR1.pdb) 
The oxygen reductases in the HCO superfamily are grouped into three subfamilies – A, B 
and C. All of the enzymes in the subfamilies share a similar subunit I which conserves the binuclear 
active site. This is expected as the B- and C-type oxygen reductases are believed to have evolved 
from the A-type oxygen reductase. (58, 59) The heme-copper oxygen reductases have the unique 
ability to pump protons from the cytoplasm to periplasm; this is achieved using conserved proton 
channels. The A-type oxygen reductase has two conserved proton channels named the D and K 
channel, named for an important residue in each channel respectively. The reduction of one 
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molecule of dioxygen requires four protons and the enzyme pumps four more. The pumped protons 
and two of the protons required for chemistry are translocated using the D channel whereas the K 
channel moves two more protons required for oxygen reduction. (61, 62) (Figure 1.5)  
 
Figure 1.5 Proton translocation pathways in A-type heme copper oxygen reductases 
The B- and C-type oxygen reductases are missing the D channel entirely and both pumped 
protons and protons for chemistry are translocated using a modified K channel. While the pumping 
efficiency of the B family is lower than that of the A family (n= 0.5 H+/e-), the number of protons 
pumped by the C-type oxygen reductase is half that of the A- family cytochrome oxidase. (n= 0.5 
H+/e-) (6, 24, 63, 64) 
The subfamilies of oxygen reductases are distinguished by their Km (O2). The A-type oxidase 
has an affinity in 0.2-1 µM range whereas the B- and C-type oxygen reductases are higher with C-
	 	10	
	
family oxygen reductases having a Km as low as 4-7 nM. (65-67) The A family oxygen reductases 
have been found in all domains of life and are energetically the most efficient while the B-family 
enzymes have been found in bacteria, and archaea  and have been associated with low-oxygen 
environments. (6, 59) Analogous to the bd-type oxygen reductase, the high affinity C-family 
enzymes are important in pathogens and also contribute to respiratory protection of nitrogenases 
in Bradyrhizobium japonicum. (66, 68) 
 
Heme-copper oxygen reductases and nitric oxide reductases 
The HCO superfamily consists of enzymes that perform both nitric oxide reductase chemistry 
as well as oxygen reductase chemistry. The nitric oxide reductases also possess a similar subunit 
I to the oxygen reductases. (69, 70) The binuclear active site where nitric oxide reduction occurs, 
however, has a heme and an iron atom, FeB in its active site as opposed to CuB. (70-72) (Figure 
1.6) Like the oxygen reductases, different NORs (nitric oxide reductases) are also capable of taking 
electrons from quinols and cytochromes c and transferring them via a low-spin heme to the 
binuclear active site. (73) Three types of NORs have thus been identified and characterized; they 
are the cNOR, qNOR and q-CuA-NOR. The first of these takes electrons from cytochrome c, the 
qNOR from quinols and the CuA-NOR was supposed to have taken electrons from both, although 
the presence of the CuA site would suggest that the natural electron donor for this NOR would be 
a cytochrome c. (74, 75) 
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Figure 1.6 The active site of P. aeruginosa shows that the binuclear active site contains Fe 
instead of Cu. The absence of the Histidine-Tyrosine crosslinked cofactor is also evident. This 
image was made using VMD and 3hb3.pdb and 3wfb.pdb. 
The cNOR and qNOR bear strong structural similarity to the C-family of oxygen reductases 
while the CuA-NOR is more like the B-family oxygen reductase, suggesting that the cNOR and 
qNOR have evolved from the C-family and the CuA-NOR from the B-family enzyme. (59) (Figure 
1.7) Rather like the CuA-NOR, which was discovered in Bacillus azotoformans, several new 
families of CuA-containing NORs have been found in genomic sequences. Sequence information 
suggests that the active sites of these new families are quite different from the previously 
characterized NORs. (74, 75) In this thesis, we have identified and characterized one of these new 
CuA-containing NORs from Rhodothermus marinus. Our evidence strongly suggests that nitric 
oxide reduction evolved from oxygen reduction not just once (as in the evolution of cNORs and 
qNORs from cbb3) but twice when the CuA-NORs evolved from the B-type family. 
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Figure 1.7 Heme-copper oxygen reductase family. This includes the previously characterized 
CuANOR from Bacillus azootoformans which is annotated here as bNOR. 
 
 
 
 
 
 
 
Reprinted (adapted) with permission of Vitaliy B. Borisov, Ranjani Murali, Marina L. Verkhovskaya, 
Dmitry A. Bloch, Huazhi Han, Robert B. Gennis, and Michael I. Verkhovsky 
Proc Natl Acad Sci USA 2011 Oct 18; 108(42): 17320-17324. doi: 10.1073/pnas.1108217108  
Copyright belongs to the authors. 
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Chapter 2: Aerobic respiratory chain of Escherichia coli is not allowed to 
work in fully uncoupled mode 
Vitaliy B. Borisova,1, Ranjani Muralib,1, Marina L. Verkhovskayac, Dmitry A. Blochc, Huazhi Hanb,  
Robert B. Gennisb, and Michael I. Verkhovskyc,2 
aBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119991, Russia; 
bDepartment of Biochemistry, University of Illinois, Urbana, IL 61801; and cHelsinki Bioenergetics Group, Institute 
of Biotechnology, University of Helsinki, PB 65 (Viikinkaari 1), FI-00014 Helsinki, Finland 
Edited* by Pierre A. Joliot, Institut de Biologie Physico-Chimique, Paris, France, and approved August 11, 2011 
(received for review May 26, 2011) 
Escherichia coli is known to couple aerobic respiratory catabolism to ATP synthesis by virtue of 
the primary generators of the proton motive force—NADH dehydrogenase I, cytochrome bo3, and 
cytochrome bd-I. An E. coli mutant deficient in NADH dehydrogenase I, bo3 and bd-I can, 
nevertheless, grow aerobically on nonfermentable substrates, although its sole terminal oxidase 
cytochrome bd-II has been reported to be nonelectrogenic. In the current work, the ability of 
cytochrome bd-II to generate a proton motive force is reexamined. Absorption and fluorescence 
spectroscopy and oxygen pulse methods show that in the steady-state, cytochrome bd-II does 
generate a proton motive force with a H+⁄e− ratio of 0.94 ± 0.18. This proton motive force is 
sufficient to drive ATP synthesis and transport of nutrients. Microsecond time-resolved, single-
turnover electrometry shows that the molecular mechanism of generating the proton motive force 
is identical to that in cytochrome bd-I. The ability to induce cytochrome bd-II biosynthesis allows 
E. coli to remain energetically competent under a variety of environmental conditions.
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2.1 Introduction 
Aerobic bacteria produce ATP via (i) oxygen-independent, substrate-level phosphorylation in 
glycolysis and the Krebs cycle, or (ii) oxidative phosphorylation, in which the electron flow, 
through the aerobic respiratory electron transport chain, generates a proton motive force (Δp%) 
which, in turn, drives the ATP synthase. The proton motive force (Δpout-in, where it is specified 
that the gradient is measured “outside-minus-inside”) is equivalent to the transmembrane 
electrochemical proton gradient and has chemical (ΔpHout-in) and electrical (ΔΨout-in) components. 
At 298 K, in mV units, 
Δpout-in = ΔΨout-in − 59ΔpHout-in 
For bacteria, such as Escherichia coli, grown at neutral pH, the major component of the proton 
motive force is ΔΨout-in, which is positive outside and typically has a value in the range of 100 to 
180 mV. Bacteria usually possess branched respiratory chains in which the different components 
are induced to allow the cells to adapt to various environmental conditions(76). One of the 
parameters that depends on the composition of the respiratory chain is the “bioenergetic 
efficiency,” which can be defined as number of charges driven across the membrane per electron 
used to reduce oxygen to water, (q⁄e−). In the E. coli respiratory chain, the net charge transfer 
across the membrane is equal to the number of protons released into the periplasm (H+⁄e−), which 
can be measured. 
The aerobic respiratory chain of E. coli (Figure 2.1) contains three enzymes that are known to 
generate a proton motive force: (i) the proton-pumping NADH:quinone oxidoreductase NADH 
dehydrogenase I (NDH-I) (H+⁄e−=2) (77); (ii) cytochrome bo3 (H+⁄e− = 2) (78), the proton-pumping 
oxygen reductase that is a member of the superfamily of heme-copper oxidoreductases (8, 79); and 
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(iii) cytochrome bd-I, which is unable to pump protons but generates a proton motive force by 
transmembrane charge separation resulting from utilizing protons and electrons originating from 
opposite sides of the membrane to generate water (H+⁄e− = 1)(8, 21, 22, 80, 81). In addition, there 
are a number of substrate dehydrogenases that are not electrogenic, including the nonelectrogenic 
NADH:quinone oxidoreductase, NDH-II (H+⁄e− = 0).	
 
Figure 2.1 Scheme of the components of the E. coli aerobic respiratory chain, starting with 
NADH as the substrate. Enzyme bioenergetic efficiency is indicated as the number of protons 
released into the periplasm per electron (Hþ⁄e− ratio). NDH-I and NDH-II are the coupled 
and uncoupled NADH: quinone oxidoreductases, respectively, and UQ-8 is ubiquinone-8. 
NDH-I and NDH-II transfer electrons to UQ-8 to yield reduced UQ-8. Three quinol:oxygen 
oxidoreductases, cytochromes bo3, bd-I, bd-II, oxidize reduced UQ-8 and reduce O2 to 2 H2O. 
Under growth conditions with high aeration, cytochrome bo3 predominates, whereas, under 
microaerophilic conditions, cytochrome bd-I is the predominant respiratory oxygen reductase that 
is present. Conditions of carbon and phosphate starvation result in the induction of a third 
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respiratory oxygen reductase, cytochrome bd-II encoded by appBC genes (also called cyxAB or 
cbdAB (82-84). The ability of cytochrome bd-II to generate a proton motive force is addressed in 
the current work. 
Whereas cytochrome bo3 and cytochrome bd-I have been extensively studied, very little is known 
about cytochrome bd-II. Cytochrome bd-I is a two-subunit enzyme carrying three hemes: b558, b595, 
and d (85-87). The latter two hemes are suggested to compose a unique di-heme site for the capture 
of O2 and its reduction to H2O. Heme d plays the major role in O2 binding and formation of 
oxygenated intermediates (17-19, 22, 88-92). In contrast, cytochrome bd-II remains poorly studied, 
but it has been shown that its spectral properties closely resemble those of cytochrome bd-I (93). 
The amino acid sequences of both subunits of cytochrome bd-I and bd-II are also highly 
homologous (about 60% identity). 
It has been reported recently that cytochrome bd-II does not contribute to the generation of the 
proton motive force (H+⁄e- = 0) (54). This was deduced from the growth properties that was 
genetically constructed to lack NDH-I, cytochrome bo3 and cytochrome bd-I. The aerobic 
respiratory chain from NADH is constrained to NDH-II →bd-II. By examination of the growth of 
this strain under glucose-limited conditions in continuous culture, it was concluded that 
cytochrome bd-II does not contribute to the proton motive force (i.e., the aerobic respiratory chain 
is fully uncoupled). Shepherd et al. (55)have proposed that under such conditions E. coli creates 
the proton motive force by means of consumption of intracellular protons during the synthesis of 
γ-aminobutyric acid (GABA), which is coupled to the electrogenic uptake of anionic glutamate by 
the glutamate/GABA antiporter. 
In this work we directly determined the ability of cytochrome bd-II to generate a proton motive 
force by examining intact cells, spheroplasts, and membrane vesicles as well as purified 
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cytochrome bd-II. The data definitively show that the catalytic turnover of cytochrome bd-II does 
generate a proton motive force by a mechanism identical to that of cytochrome bd-I. A previous 
proposal (94) that the bd-type oxygen reductase from Azotobacter vinlandii is not coupled has also 
been demonstrated not to be correct (7). It is very likely, therefore, that all members of the family 
of bd-type oxygen reductases generate a proton motive force even as they may have additional 
roles such as scavenging O2 or maintaining redox balance in the cytoplasm. The data presented has 
import in examining the bioenergetics of other organisms which use cytochrome bd. 
2.2 Results 
Steady-State Generation of ΔΨ and ΔpH. ΔΨ and ΔpH measurements were performed with 
inverted membrane vesicles of E. coli strain MB37 lacking NDH-I, cytochrome bo3, and 
cytochrome bd-I. Thus, all three of the known electrogenic components of the aerobic respiratory 
chain are absent. NADH oxidation can proceed via the NDH-II →bd-II branch (Fig. 2.1). Fig. 
2.2A shows that the addition of ATP (trace 1) or the substrate of bd-II [Q1 plus a reductant DTT 
(trace 2)], results in a spectral shift of oxonol VI, indicating the formation of ΔΨ in the inverted 
vesicles (inside positive). The ΔΨ is entirely eliminated upon the addition of gramicidin, which 
creates channels in the membrane. These data show that ΔΨ across the bacterial membrane is 
generated due to either turnover of the F1FO ATPase (trace 1) or by quinol oxidase activity (trace 
2). Because the only quinol oxidase present is cytochrome bd-II, these data imply that catalytic 
turnover of cytochrome bd-II generates a transmembrane potential (ΔΨ) under steady-state 
conditions. 
Fig. 2.2B shows the responses of the dye acridine orange (AO) under the same conditions, 
reporting the internal acidification in the inverted vesicles, and, therefore, formation of ΔpH. The 
addition of either ATP (trace 1) or Q1 plus DTT (trace 2) results in quenching of the AO 
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fluorescence, demonstrating acidification of the vesicle interior. These pH changes are abolished 
by gramicidin. The data clearly show that catalytic turnover of cytochrome bd-II is accompanied 
by the release of protons on the periplasmic side of the membrane, equivalent to the inside of the 
inverted vesicles. 
 
Figure 2.2 Steady-state generation of Δp by the inverted membrane vesicles from an E. coli 
strain engineered to contain cytochrome bd-II as the only terminal oxidase. (A) ΔΨ 
generation measured with 25 mM HEPES + BIS-TRIS propane at pH 7.5, 1 mM MgCl2, 2 
µM oxonol VI, and vesicles (72 µg protein/ mL). The arrows show that the reaction was 
initiated by addition of 1 mM ATP (trace 1) or 50 µM Q1 in the presence of 1 mM DTT and 
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Figure 2.2 (contd.) 6.25 mM (NH4)2SO4 (trace 2). The ΔΨ was then dissipated by the addition 
of 1 µg⁄mL gramicidin (Gr). (B) Acidification of the vesicle interior measured with 100 mM 
HEPESKOH at pH 7.5, 50 mM K2SO4, 5 µM AO, vesicles (36 µg protein/mL), and 1 µM 
valinomycin. The reaction was initiated by addition of 0.1 mM ATP in the presence of 10 
mM MgSO4 (trace 1) or 1 mM DTT in the presence of 50 µM Q1 and 1 mM MgSO4 (trace 2). 
The generated ΔpH was then dissipated by 1 µg⁄mL gramicidin (Gr), as indicated by the 
arrows. 
It is noted that the observed kinetics of the generation of ΔΨ and ΔpH are different (Fig. 2.2). 
This is because ΔΨ is produced almost immediately, whereas ΔpH develops at a much slower 
rate since the membrane vesicles are loaded with concentrated buffer.  
H+/e− Ratio Measurement. Figure 2.3 shows the change in the pH of an anaerobic suspension of 
spheroplasts from E. coli MB37 (lacking NDH-I, cytochrome bo3 and cytochrome bd-I) upon 
addition of aliquots of O2. By calibrating with HCl, the number of released protons can be 
calculated as 0.94 ±0.18 H+⁄e−. The data is an average of nine measurements with two different 
spheroplasts preparations. As shown in Fig. 2.3A, under identical conditions virtually the same 
ratio (1.0 ± 0.07 H+⁄e−) can be obtained with spheroplasts from strain MB30, in which NDH-I, 
cytochrome bo3, and cytochrome bd-II have all been removed. The only possible source of released 
protons in strain MB30 is cytochrome bd-I. This data is an average of 12 measurements with two 
different spheroplast preparations. The H+⁄e− stoichiometry for cytochrome bd-I is in agreement 
with that reported earlier (8). O2 pulses were also performed with whole cells at pH 7.3 and the 
results are the same as with the spheroplasts at pH 5.0. The proton release from spheroplasts, by 
either cytochrome bd-I or cytochrome bd-II, is inhibited by the addition of aurachin (C1-10), an 
inhibitor of the quinol oxidases. 
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Figure 2.3 Proton release from spheroplasts prepared from (A) E. coli strain MB30 [ΔcyoB 
ΔappB ΔnuoB] in which cytochrome bd-I is the only terminal oxidase present; and (B) E. 
coli strain MB37 [ΔcyoB ΔcydB ΔnuoB] in which cytochrome bd-II is the only terminal 
oxidase present. For conditions, see the text. O2 was added as air-saturated water (25 °C, 1 
atm). 
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Single-Turnover Generation of Membrane Potential. Figure 2.4 shows the time course of 
single-turnover ΔΨ generation by the liposome incorporated, fully reduced cytochrome bd-II 
during its reaction with O2. The electrometric kinetics consists of an initial lag-phase reflecting a 
nonelectrogenic process, followed by an electrogenic phase. Fitting the kinetics with a sequential-
step reaction model (95) gives two electrically silent steps with time constants (τ) of 2.1 and 7.3 
µs, respectively, for the lag phase, and two steps with τ of 70 µs and 440 µs and with their relative 
amplitudes of approximately 90% and 10%, respectively, for the electrogenic phase. Similar 
kinetics of ΔΨ generation by cytochrome bd-I has been demonstrated previously under the same 
conditions (80). In the latter work, based also on the concomitant time-resolved optical 
measurements, the two nonelectrogenic steps have been correlated to the transition from the 
reduced heme d (state R) to the heme d oxy-complex (state A) followed by the formation of the 
heme d peroxy complex (state P). The two electrogenic steps correlate with the sequential 
conversion of the peroxy intermediate to the ferryl species (state F) and then to the oxidized species 
(state O). Note that the F→O transition occurs only in a small fraction of the enzyme that contains 
bound quinol. For this reason, this reaction is associated with a relatively small electrogenic 
amplitude (10% of the total voltage). The data demonstrate that the two enzymes, bd-I and bd-II, 
function in the same manner. 
2.3 Discussion 
The current work was inspired by the report by Bekker et al. (54) concerning the function of 
cytochrome bd-II in the E. coli aerobic respiratory chain. By constructing a strain (MB37; cyo, 
cyd, nuo) in which the only terminal oxidase is cytochrome bd-II, aerobic respiration utilizing this 
enzyme was clearly demonstrated and quantified during continuous culture under glucose-limited 
growth conditions. If all three terminal oxygen reductases were absent, no oxygen utilization was  
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Figure 2.4. Single-turnover generation of the transmembrane electric potential during the 
reaction of the fully reduced, reconstituted cytochrome bd-II from E. coli with O2. 
Conditions: 100 mM MOPS-KOH at pH 7.2, 10 µM hexaammineruthenium, 5 µM 
N,N,N’,N’-tetramethyl-p-phenylendiamine, 50 mM glucose, 0.5 mg⁄mL catalase, 1.5 mg⁄mL 
glucose oxidase and 1% CO. The reaction was started by a laser flash (time ¼ 0, indicated 
by a dashed line) 400 ms following the injection of 50 µL of oxygen-saturated buffer (½O2 
¼ 1.2 mM) at 21 °C. The fit line is a best fit result for a consecutive-step reaction model with 
two lag-phases (electrically silent steps, τ, 2.1 µs and 7.3 µs, respectively) and two ΔΨ 
generation steps (τ, 70 µs, and contribution, 90%, and τ, 440 µs, and contribution, 10%, 
respectively). The respective phases are indicated by arrows. The time constants for bd-I 
are taken from ref. 10. 
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observed and the strain (MB44) grows by homolactate fermentation (54). Despite the fact that the 
strain in which cytochrome bd-II is the only terminal oxidase consumes oxygen, a detailed analysis 
resulted in the conclusion that cytochrome bd-II does not contribute to the proton motive force 
(54). Hence, according to these data, strain MB37 lacks all three of the respiratory components that 
contribute to the proton motive force, leaving open the question of how ATP is generated. 
Substrate-level phosphorylation was suggested (54) and, subsequently, it was suggested that a 
proton motive force could be generated by the operation of an electrogenic antiporter that imports 
anionic glutamate and exports newly synthesized, neutral GABA (55). According to this 
interpretation, E. coli cells have the capacity to insert into its respiratory chain a terminal oxidase 
that is maximally coupled to the generation of the proton motive force (bo3 : H+⁄e− = 2), minimally 
coupled (bd-II : H+⁄e− = 0), or intermediate (bd-I: H+ /e− = 1), depending on the physiological need.	
    In the current work, the ability of cytochrome bd-II to generate a proton motive force was 
directly measured. Contrary to the expectation based on the continuous culture experiments (54), 
it is definitively shown that catalytic turnover of cytochrome bd-II does generate a proton motive 
force. Steady-state ubiquinol-1 oxidase (H+⁄e− = 1). The same result was obtained with cytochrome 
bd-I (Figure 2.3A) but is half the value reported previously for cytochrome bo3 (8), which is a 
proton pump. Hence, these data indicate that cytochrome bd-II, like cytochrome bd-I, is not a 
proton pump. The scheme in Figure. 2.5 shows how this stoichiometry is attained. Charge 
separation accompanies catalytic turnover of the enzyme because the electrons and protons used 
to reduce O2 to 2 H2O come from opposite sides of the membrane. Quinol is oxidized at a site near 
the periplasmic surface, releasing protons into the periplasm. The protons used to form H2O are 
taken from the cytoplasm delivered across the membrane by a putative proton conducting channel. 
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Figure 2.5. Schematic model of 
coupling between respiration and 
phosphorylation in E. coli in which 
the aerobic respiratory chain in 
which cytochrome bd-II is the only 
site that can generate a proton 
motive force. Shown are 
cytochrome bd-II (green) and the 
F1FO-ATP synthase (pink) 
embedded in the cytoplasmic 
membrane (yellow). The same 
diagram applies also to cytochrome 
bd-I. The proton motive force is 
composed of two components that 
depend on the magnitude of the transmembrane electric potential difference (ΔΨ) and the 
pH gradient across the membrane. In vivo, the pH gradient is determined by the buffering 
of the external environment and by pH homeostasis mechanisms to control the internal pH. 
In inverted membrane vesicles, the small internal volume is readily acidified by proton 
release from the oxidation of ubiquinol. The transmembrane potential is postulated to be 
formed by the vectorial uptake of protons from the cytoplasmic side of the membrane to the 
di-heme (b595-d) active site to form water. The resulting proton motive force is used by the 
F1FO-ATP synthase to produce ATP from ADP and inorganic phosphate. 
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Single-turnover electrometric experiments with the purified cytochrome bd-II incorporated in 
proteoliposomes allowed us to elucidate which of the partial reactions in the catalytic cycle are 
coupled to the generation of membrane potential. The ΔΨ transient caused by the reaction of the 
fully reduced cytochrome bd-II with O2 consists of an initial, nonelectrogenic part (the lag-phase) 
followed by the electrogenic part (Figure 2.4). The lag phase is the sum of the two faster, 
nonelectrogenic processes and the electrogenic part consists of two slower electrogenic transitions 
with the first phase contributing the most to the ΔΨ. The phases and rate constants are similar to 
those activity by inverted vesicles of strain MB37, in which cytochrome bd-II is the only quinol 
oxidase, is coupled to the generation of both the ΔΨ and ΔpH components of proton motive force 
(Figure 2.2). Because inverted vesicles from this strain also contain a well-coupled F0F1-ATPase, 
both ΔΨ (Figure 2.2A, trace 1) and ΔpH (Fig. 2.2B, trace 1) can also be generated by addition of 
ATP. Hence, in the MB37 cells, aerobic respiration must be coupled to ATP synthesis via the 
cytochrome bd-II terminal oxidase. 
 
2.4 Materials and Methods 
Cell Culture. The E. coli strains MB37 (BW25113 ΔcyoB ΔcydB ΔnuoB, kanamycin marker 
removed) and MB30 (BW25113 ΔcyoB ΔappB ΔnuoB, kanamycin marker removed) containing 
cytochrome bd-II and cytochrome bd-I as the sole terminal oxidase, respectively (54), were a kind 
gift of M. Bekker (University of Amsterdam). The cells were grown aerobically in a 25 L fermentor 
with stirring (at aeration rate of 20 L⁄min) or in flasks on a shaker (at 200 rpm) in LB medium at 
37 °C for 4–5 hrs until the late exponential phase. 
Enzyme Isolation. Cytochrome bd-II was purified following a protocol described for cytochrome 
bd-I (32), with modifications. The MB37 membranes were solubilized with sucrose monolaurate 
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(1.8% final concentration). After solubilization, the membranes were centrifuged (160;000 g ×60 
min, 4 °C), the pellet was discarded and the supernatant loaded on a DEAE-Sepharose Fast Flow 
column equilibrated with 50 mM potassium phosphate buffer also containing 25 mM KCl, 5 mM 
EDTA, and 0.1% sucrose monolaurate, pH 6.5. The elution was performed with a KCl gradient 
(25–470 mM). The fractions with an absorbance ratio of A412⁄A280 ≥0.7 were collected and 
concentrated. 
Steady-State Generation of ΔΨ and ΔpH. For these measurements, inverted membrane vesicles 
were prepared. The cells were converted into spheroplasts by treatment with 0.1 mg⁄mL lysozyme 
in 200 mM Tris-HCl, 2 mM EDTA at pH 8.0, and 30% sucrose. The spheroplasts were pelleted at 
5;000 g× 10 min, suspended in 100 mM HEPES-KOH, 50 mM K2SO4, 10 mM MgSO4 at pH 7.5, 
2 mM dithiotreitol (DTT), and 0.5 mM phenylmethanesulfonyl fluoride and sonicated. The cell 
debris was removed by centrifugation (at 5;000 × g for 10 min). The supernatant was 
ultracentrifuged at 120;000 × g for 30 min. The membrane vesicles were suspended in 25 mM 
HEPES + BIS-TRIS propane at pH 7.5 and used the same day. Steady-state generation of ΔΨ by 
the vesicles was monitored by the spectral shift of the lipophilic anionic dye oxonol VI. The 
absorption changes were followed in dual wavelength kinetics mode (588–625 nm) using a 
Shimadzu UV-3000 spectrophotometer. Acidification of the interior of the vesicles was followed 
by quenching of fluorescence of the pH-sensitive membrane-permeable dye AO. Measurements 
were carried out at 21 °C using a Hitachi F-4000 fluorescence spectrophotometer using 493 nm 
(excitation) and 530 nm (emission). The response was expressed as the percentage of the 
fluorescence intensity before addition of the substrate. 
Measurement of H+⁄e− Ratio. The measurement was performed both with spheroplasts and intact 
cells. Spheroplasts were prepared using lysozyme and EDTA as in ref. (96), collected by 
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centrifugation and then resuspended in 0.5 mM HEPES-KOH at pH 5.0, 100 mM KSCN, and 
150 mM KCl. Then spheroplasts were pelleted once again and resuspended in the same medium. 
Proton release by whole cells was studied at pH 7.3, whereas experiments with spheroplasts were 
performed at the pH value of 5.0 to optimize their stability (97). The results were similar whether 
intact cells or spheroplasts were examined. Spheroplasts were used to determine if the proton 
translocation and oxidase activities were inhibited by aurachin (C1-10), a potent inhibitor of 
cytochrome bd-I (98, 99) that does not readily penetrate the outer membrane of intact cells. Proton 
release by spheroplasts was measured as follows. The spheroplast suspension (100 µL) was 
diluted into 2.5 mL of 0.5 mM HEPES-KOH at pH 5.0, 100 mM KSCN, and 150 mM KCl. 
Dissolved oxygen was removed by passing a stream of water-saturated argon over the solution in 
a sealed chamber (at 25 °C) equipped with a glass pH-electrode (Thermo Russell pH electrode, 
type CMAW711). Traces of oxygen were removed from the solution by letting the spheroplasts 
respire with endogenous substrates. Endogenous substrates are also responsible for the respiration 
during the oxygen pulse used to measure the proton release. To measure the H+⁄e− ratio, 10 µL of 
air-saturated water (250 µM) was injected into the solution and the pH change was recorded. 
After reequilibration, 10 µL of a 1 mM HCl solution was injected into the sample and the pH 
change was recorded as a calibration of the system. The number of protons ejected from the 
spheroplasts upon the reduction of O2 contained in 10 µL of airsaturated water (250 pmole⁄µL) 
was calculated by noting the amount of HCl required to elicit the same change in pH. The addition 
of aurachin (C1-10) to a final concentration of 80 µM eliminated proton translocation for both 
cytochrome bd-I and cytochrome bd-II in the spheroplast preparations. 
Oxidase Activity Assay. Oxidase activity was measured by monitoring the depletion of dissolved 
oxygen as a function of time using a Clark-type electrode (YSI Inc.) at 37 °C after the addition 
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of 100 µL of a suspension of either whole cells or spheroplasts to 1.7 mL of the same buffer used 
for proton-pumping measurements. 
Single-Turnover Generation of ΔΨ. Reconstitution of cytochrome bd-II into liposomes, 
preparation of the anaerobic samples, and the direct electrometric measurements with a 
microsecond time resolution were performed essentially as reported (refs. 8–11 and references 
therein). 
Heme and Protein Concentration. The heme d content was measured from the reduced-minus-
“air-oxidized” difference absorption spectra using Δϵ628-607 of 10.8 mM−1 cm−1 (20). Protein 
concentration was determined by the BCA Protein Assay Reagent kit (Pierce) with bovine serum 
albumin as a standard. 
Data Analysis. MATLAB (The Mathworks) and Origin (OriginLab Corporation) were used for 
data manipulation and presentation. 
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Chapter 3: Denitrification in Rhodothermus marinus and a novel nitric oxide 
reductase 
3.1 Introduction 
Nitrous oxide is an important greenhouse gas, comparable to CO2 and CH4 in the damage 
it causes. Its effect is particularly concerning because it is very stable in the atmosphere, with a 
lifetime of a 114 years. The Ozone Depletion Potential (ODP) for N2O is similar to that of 
chlorofluorocarbons and N2O emission is now the major cause of ozone depletion (100, 101). Most 
of the N2O released into the atmosphere comes from anthropogenic activities like agriculture. In 
agriculture, nitrogen containing compounds are used as fertilizers and microbial processes like 
denitrification and nitrification produce N2O. It has recently also been shown that a significant 
amount of nitrous oxide is released by nitrifying and denitrifying bacteria in the oceans, 
particularly in the oxygen minimum zones (102). In this context, studying the microbial generation 
of N2O is imperative. In this paper we present evidence for the discovery of a new enzyme 
responsible for the production of N2O from NO, as part of the denitrification pathway in 
Rhodothermus marinus.  
Denitrification is the process of reduction of nitrate to nitrogen by a series of enzymes 
present in bacterial and archaeal electron transport chains. (Figure 3.1) Sometimes this pathway is 
terminated at the conversion of NO to N2O, which is not further reduced to N2. This is referred to 
as incomplete denitrification. Nitrous oxide reductase which reduces N2O to N2 is inhibited by 
oxygen and therefore it is typical for this final reduction step to be absent under higher 
concentrations of oxygen (102, 103). In this chapter, we describe the denitrification of an aerobic 
denitrification pathway in Rhodothermus marinus. 
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Figure 3.1 Schematic of denitrification pathway. The nitrate reductase can sometimes also 
be a transmembrane protein. 
As discussed in Chapter 1, the Heme-copper oxygen reductase superfamily contains many 
enzymes which perform either oxygen reductase or nitric oxide reductase chemistry. This enzyme 
superfamily has been shown to have many divergent members, which have modified versions of 
the active site, proton channels and electron donor site which allow the enzymes to adapt to novel 
environments while performing either the oxygen or nitric oxide reduction chemistry (6, 59). There 
are three families of oxygen reductases – A, B and C, where B and C families evolved from A. Of 
the three NOR families previously studies, cNOR and qNOR appear to have evolved from the C 
family, while the CuANOR evolved from the B-family oxygen reductase. Using Genomics and 
structural modeling, several new families performing nitric oxide reduction were hypothesized, all 
of them supposed to have evolved from the B family oxygen reductase (59). (Figure 3.2) In this 
work, we have verified that one of the hypothesized family of NORs does in fact perform nitric 
oxide reduction chemistry.  
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Figure 3.2 Heme-copper oxygen reductase superfamily. New families eNOR, bNOR, sNOR 
and gNOR are represented. 
3.2 Results 
Denitrification in Rhodothermus marinus:   
Rhodothermus marinus is a bacteroidete from the family Rhodothermaceae. It was isolated 
from an Icelandic hot spring, and is a thermohalophile (104). While the water from hot springs 
does not contain nitrate, it does contain ammonia and, ammonia oxidizers have been found in hot 
springs to convert ammonia to nitrate. This nitrate can then be reduced to nitrous oxide or nitrogen 
(105). A few thermophilic denitrifiers have been thus far identified (106, 107). In the original 
cultivation studies, nitrate reduction was not observed, however some genes for denitrification are 
present in Rhodothermus marinus DSM 4252. (Figure 3.3) The genes for the periplasmic nitrate 
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reductase NapAB are encoded for in the genome and so are the genes for the copper-dependent 
nitrite reductase (nirK) and the cytochrome cd1- containing nitrite reductase (nirS). The genes 
known for nitric oxide reduction (cNOR and qNOR) are conspicuously absent. However, the genes 
for reduction of nitrous oxide, the product of the reaction that would be catalyzed by the NORs is 
present. We believe that the absence of genes encoding for previously characterized NORs is 
because the function is performed by an uncharacterized enzyme, the eNOR that was hypothesized 
by Hemp et al. (59). 
 
Figure 3.3 KEGG pathway in nitrogen metabolism in Rhodothermus marinus DSM 4252. 
Created with use of Data analysis software on the IMG site.  
Here, we show that Rhodothermus marinus reduces NO3- to N2 under aerobic conditions. 
When grown under denitrifying conditions (in the presence of 30 – 50 mM NO3-), NO3- utilization 
is observed (data not shown). Further, the accumulation of nitrous oxide is observed when 
organisms grown under denitrifying conditions are inoculated incubated for 30 minutes. (Figure 
3.4) This suggests very strongly that nitrous oxide is formed as an intermediate during 
denitrification, suggesting that there exists a nitric oxide reductase. When the above incubation is 
performed with acetylene, excess nitrous oxide is accumulated, indicating the presence of nitrous 
oxide reductase which is inhibited by acetylene. Our data not only confirms that Rhodothermus 
marinus is a denitrifier but, suggests that a novel nitric oxide reductase (not homologous to 
previously characterized NORs) is present in the organism. 
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Figure 3.4 Nitrous oxide production by Rhodothermus marinus during denitrification. R. 
marinus grown under denitrifying conditions, was inoculated into fresh mediumincubated in 
septum stoppered bottles and incubated for 30 minutes at 65 °C. The headspace was then 
analyzed for nitrous oxide accumulation in the presence and absence of acetylene, an 
inhibitor of nitrous oxide reductase. 
Biochemical characteristics of eNOR:  
A nitric oxide reductase of the designated eNOR family was expressed in Rhodothermus 
marinus by growing it under denitrifying conditions, and then purified in its native form. A very 
closely related eNOR was purified earlier from Magnetospirillum magnetotacticum (originally 
Aquaspirillum magnetotacticum) but was not tested for nitric oxide reductase activity. The eNOR 
from Rhodothermus marinus in a partially pure state (Figure 3.5) was shown to have two subunits 
– subunit I of approximately 40 kDa and subunit II of around 20 kDa. The theoretical prediction 
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of molecular weight for subunit I is 62 kDa but, it is not unusual for membrane proteins to run at 
a lower weight than expected. Moreover, the electrophoresis pattern is similar to the one observed 
for the protein purified from Magnetospirillum (108). The identity of the Rhodothermus marinus 
eNOR was ascertained by LC/MS analysis after peptide digestion. In the peptide analysis, 24 % 
of subunit I’s sequence was covered with a MASCOT score of 354 and 60 % of subunit II’s 
sequence was covered with a MASCOT score of 2022. (Details of MS analysis in Supplementary 
information) 
 
Figure 3.5 Electrophoretic analysis of eNOR via SDS-PAGE gel. 
The eNOR was then shown to have nitric oxide reductase activity with a turnover number 
of 0.68 ± 0.21 NO/s (n= 4) and virtually no oxygen reductase activity (less than 0.07 O2/s). (Figure 
3.6) The NO reductase activity was confirmed by establishing N2O production as a result of eNOR 
enzymatic activity, by using Gas chromatography followed by Electron Capture Detection (ECD). 
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Detection by ECD is an established method for detecting nitrogen oxides in a gaseous mixture. 
(Figure 3.7) 
 
Figure 3.6 Nitric oxide reduction activity of eNOR using PMS and Ascorbate as electron 
donors. Analyzed used WPI ISO-NOP electrodes. 
 
Figure 3.7 Nitrous oxide is the product of the reaction between eNOR and NO in the presence 
of PMS and Ascorbate. 
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The heme co-factors in eNOR:  
Since the eNOR is similar to the B-family oxidase, it was expected to have two heme co-
factors like the ba3 oxidaseeNOR. While the heme-copper oxidase family enzymes were 
previously found to use a, as, b or o hemes, the eNOR is suspected to have unusual co-factors (59, 
109). The UV-visible spectra of the heme co-factors in this eNOR as well as the proposed NOR 
from Magnetospirillum are unique. (Figure 3.8a and (108)) The pyridine hemochrome spectra 
largely indicate the presence of only one type of heme, which when extracted by pyridine absorbs 
at 583 nm, as in the earlier work. The α-band of the hemes is close to, however, blue-shifted in 
comparison to other a-type hemes. (Figure 3.8b)  
 
Figure 3.8a The UV-visible spectral properties reveal a novel heme-cofactor b. The pyridine 
hemochrogen assays reveals a unique absorption peak. 
When analyzed by LC/MS, the elution profile of extracted hemes from eNOR reflects a 
different pattern from those of heme a from bovine heart and heme b. (Figure 3.9) The molecular 
weight of the eNOR heme was found to be around 647 Da. Theoretically, the structure that would 
most approximate this weight could use two formyl modifications in the place of methyl groups in 
a b-type heme. (This would add up to a molecular weight of 644 Da.) However, this observation 
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of a novel heme will require further and more rigorous analysis before it can be confirmed. The 
question of which metal occupies the binuclear active site has not been resolved in this work. 
However, previous observations about the heme-copper oxidase superfamily suggest that copper 
is present in the active site when the histidine tyrosine crosslink is present and iron is present when 
other ligands are present. The sequence and structural alignment of the eNOR suggest that there is 
no tyrosine, which  that could act as the crosslink. 
 
Figure 3.9 Elution profile of hemes extracted from a) bovine cytochrome c oxidase b) 
cytochrome ba3 from Thermus thermophilus and c) eNOR. 
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Structural characteristics of eNOR using a structural model 
A computationally generated model of the eNOR on the i-TASSER server was found to 
align very well with the crystal structure of ba3 oxidase from Thermus thermophilus (PDB code: 
1XME). The RMSD of the structure was found to be within 2 Å, and a number of structural features 
were clearly seen to be conserved. The ligands to the CuB (H241, H290, and H291) and the heme 
(H77, H398) in the binuclear site correlate to the corresponding geometric positions in ba3 though, 
the side chains are not directly superimposable. The numbering used in the figure is based on the 
amino acid numbering in the eNOR. It is evident that no Tyrosine exists in the model that could 
serve as a crosslink to the Histidine ligand to the CuB, as in the oxygen reductases. Instead, a 
Glutamine (Q245) takes its place and we suggest that it could act as a ligand to the FeB, like the 
Glutamate in the cNOR and qNOR (70, 72, 110). The ligand (H396) to the second heme in subunit 
I is identical to Histidine 384 in ba3. Ligands to the CuA site in subunit II (H126, C161, C165, 
H169 and M172) are also present. 
Most interestingly, there are three completely conserved residues (Y256, S318Y280 and 
H321E330) which are very similarly placed to residues in the K channel of the ba3 oxidase (Y248, 
S309 and T312 respectively) (24). S269 is in a similar position to T315 and is 98 % conserved. 
(Figure 3.10, 3.11) (Sequence analysis data in supplementary information) There is a Glutamate 
in an equivalent position in subunit II to E15 from ba3. Y280 is completely conserved and is in the 
vicinity. There is no geometrically equivalent residue in the ba3 oxidase. We think that it is quite 
possible that these residues constitute a proton channel for the transfer of protons from the 
cytoplasm to the active site. If that is true, it is possible that the eNOR could be electrogenic, which 
has been previously suggested by Hemp et al. (59). This has also been suggested of the qNOR but, 
has not yet been proven. (72, 73) 
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Several other residues near the active site are conserved – S318, H321, Y232, N384 and 
H388 – are also completely conserved, but, it is not immediately apparent what their functions are. 
 
Figure 3.10 Subunits I of T. thermophilus ba3 and R. marinus eNOR indicating the presenc 
of a K-channel for translocation of protons from the cytoplasm to periplasm. 
Figure 3.11 The conserved proton channel in a) ba3 and b) in the putative proton pathway in 
eNOR.  
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3.3 Discussion 
Genomics has long predicted the existence of a number of uncharacterized families of heme-
copper oxygen reductases (58). Structural modeling and previous biochemical evidence have led 
to the prediction of function for several of these new families as nitric oxide reductases (59). Prior 
to these predictions, a novel CuA containing NOR was purified and characterized from Bacillus 
azotoformans (75, 111). This NOR is closer in structure to the B-family oxygen reductase than the 
C-family oxygen reductase and is expected to have evolved from the B-family oxygen reductase. 
According to the notation presented here, this would be the bNOR. Most of the proposed new 
families of oxygen reductases are likewise expected to have evolved from the B-family oxygen 
reductase. We have in this work, verified the existence of one of these family of nitric oxide 
reductases, the eNOR. This has interesting implications for the study of denitrifiers since this NOR 
was isolated from an obligate aerobe (112). Denitrification typically occurs under anaerobic 
conditions or in oxygen minimum zones (102). Further more, the possibly formylation of the co-
factor in eNOR is also interesting as the enzyme responsible for formylation of hemes is only 
produced under aerobic conditions(113). The use of denitrification in aerobic conditions and their 
impact on the nichess,   denitrifiers possessing the eNOR can occupy requires further 
consideration.  
 Our structural model and sequence analysis of eNOR reveals conserved polar residues 
which could form a possible proton channel. The bNOR from Bacillus azotoformans has been 
shown to have a conserved proton channel, which contributes to proton motive force generation 
(114). Likewise, we suggest that eNOR could be electrogenic. This would have serious 
implications for questions of energy conservation in denitrification as this would significantly 
increase the amount of energy that can be conserved by denitrification. 
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3.4 Materials and Methods 
Growth and Expression Conditions 
Rhodothermus marinus DSM 4252 was inoculated from frozen stock and grown in 5 ml of 
DSM Medium 630 with 10 g/L NaCl at 60 °C for 36 hrs. It was then inoculated into a larger 
secondary culture and grown overnight. 25 ml of the culture was inoculated into 1 L of medium 
with 30 mM nitrate added. The cells were shaken at 75 rpm and grown at 60 °C. The cells were 
collected by centrifugation at 8000 rpm.  
Purification of eNOR 
 The culture of Rhodothermus marinus, once harvested, was resuspended in 100 mM Tris-
HCl, pH 8 with 10 mM MgCl2 and 50 µg/ml DNase, using a Bamix homogenizer. The resulting 
solution was spun down at 42000 rpm in a Beckman Ultracentrifuge. The membrane pellet was 
collected and resuspended in 20 mM Tris-HCl, pH 7.5, 1 % CHAPS (Affymetrix) to a final 
concentration of 40-50 mg/ml. The solution was stirred at 4 °C for 1 hr. In this step a lot of 
peripheral membrane proteins appear to be solubilized and the remaining protein is pelleted by 
spinning down at 42000 rpm for 1 hr. The remaining pellet is then solubilized in 20 mM Tris-HCl, 
pH 7.5, 1 % DDM (Affymetrix) at a final protein concentration of around 5-10 mg/ml. The DDM 
solubilized fraction was once again centrifuged at 42000 rpm to pellet down protein that was not 
solubilized.  
The solubilized protein was then loaded on a DEAE CL-6B (Sigma) column, pre-
equilibriated in 20 mM Tris-HCl, pH 7.5, 0.05 % DDM, and subjected to a linear gradient spanning 
from 0 to 500 mM NaCl. The fraction containing the NOR, which eluted at around 200 mM salt, 
was then loaded on a Q Sepharose High Performance (GE Healthcare) column, pre-equilibriated 
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with 20 mM Tris-HCl, pH 7,5, 0.05 % DDM and then eluted in a gradient from 0 to 1 M NaCl. 
The eNOR was eluted at around 250 mM salt and the eluted fraction was then loaded on a 
Chelating Sepharose (GE Healthcare) column, loaded with Cu2+ and equilibriated with 20 mM 
Tris-HCl, 500 mM NaCl, as previously described for cytochrome caa3 from Rhodothermus 
marinus (115). The NOR, identified by a spectroscopic peak at 591 nm was once again loaded on 
a Q Sepharose High performance column, and a gradient was run between 0 and 300 mM NaCl 
and the first peak was found to be the eNOR. 
Gel Electrophoresis 
The purified eNOR was run on a Tris-Hepes 4-20 % acrylamide gel (NuSep) in the 
recommended Tris-Hepes-SDS running buffer at 120 V for ~1 hr. The protein was viewed with 
respect to the Precision Plus Protein™ Dual Color Standards (BIO-RAD).  
UV-Visible Spectroscopy 
All spectra were recorded on a HP Agilent 8453 UV-Vis spectrophotometer using a quartz 
cuvette from Starna Cells (No. 16.4-Q-10/Z15). Potassium Ferricyanide was used to obtain the 
oxidized spectrum, and dithionite was used to obtain the reduced spectrum. 
Pyridine Hemochrome Assay 
The hemes in eNOR were analyzed using a pyridine hemochrome assay (116). A stock 
solution of 200 mM NaOH with 40 % pyridine was prepared. The stock solution was mixed 1:1 
with the protein and an oxidized spectrum was obtained by adding 3 µl of 100 mM K3Fe(CN)6. A 
reduced spectrum was similarly prepared by adding a few crystals of sodium dithionite. The 
reduced minus oxidized spectrum was used to identify the heme co-factors. 
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Heme extraction and HPLC Analysis 
The hemes from eNOR were extracted and analyzed using an HPLC elution profile 
according to established protocols (117, 118). 50 µl of eNOR was mixed with 0.45 ml of acetone 
/ HCl (19:1) and shaken on a rotary shaker for 20 minutes at room temperature. The mixture was 
centrifuged at 14000 rpm for 2 minutes, followed by addition of 1 ml of ice cold water, and 0.3 ml 
of ethyl acetate to the supernatant. The water/ethyl acetate mixture was vortexed and centrifuged 
again for 2 minutes. The ethyl acetate phase was recovered and concentrated using a speed vac. 
The extracted hemes were analyzed using a Hewlett-Packard 1090 Series HPLC by 
separation on a DeltaPak C18 column, and an acetonitrile (0.05 %TFA) / water (0.05 % TFA) 
gradient from 50 to 100 %.  
NO reductase activity verification using GC 
Anaerobic reaction conditions were set up in a 5 ml clear serum vial (Voigt Global 
Distribution, Inc) sealed with a 20 mm rubber stopper, by passing N2 through 2 ml of 20 mM KPi, 
0.05 % DDM, pH 7.5 with 1 mM TMPD, 5 mM Ascorbate. A control was performed by adding 
only 50 µM NO. Sample reactions were begun by adding eNOR to a final concentration of 100 
nM. The reaction was incubated at 42 °C for half an hour before the head space was injected into 
an HP Agilent 5890 Series GC, fitted with a TCD and ECD (SRI Instruments) for verification of 
N2O production.  
Turnover measurement using a Clark electrode 
A sealed chamber fitted with an ISO-NO (World Precision Instruments) electrode was used 
for NO reductase activity measurements. 1 mM TMPD or 100 µM PMS and 4 mM Ascorbate were 
was added to 2 ml 50 mM Citrate, pH 6, 0.05 % DDM in the reaction chamber and all traces of 
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oxygen were removed by passing water-saturated Argon for 20 minutes through the solution. The 
buffer system also contained an oxygen scavenging system constituting 100 nM catalase, 35 nM 
Glucose oxidase and 90 nM Glucose. The NO reduction traces were recorded using a Duo-18 
(World Precision Instruments), and activities calculated from the slope of the traces.  
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3.5 Supplementary Information 
Figure 3.12 Mass spectrometric analysis of eNOR subunits. 
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Figure 3.13: Sequence alignment for sequences from the B-family oxygen reductase and 
eNOR. This highlighted sequences calls attention to the conserved active site motif 
(HXXVY) which binds to CuB and (HXXQQ) which we expect would bind FeB . 
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Chapter 4. Investigation of the role of E445 in the active site of cytochrome bd 
from Escherichia coli 
4.1 Introduction 
 Cytochrome bd-type oxygen reductases have a unique active site, standing in contrast to 
the better understood heme-copper oxygen reductases which incorporate a heme and copper in 
their active site. Cytochrome bd-type oxygen reductases have three heme co-factors to catalyze 
the reduction of oxygen to water (11). Cytochrome bd extracts electrons from a membrane-bound 
quinol at a quinol binding site, using heme b558, a low spin heme. The electrons are then transferred 
to a di-heme active site consisting of two high spin hemes – heme b595 and heme d (17). Heme d 
is a chlorin, a reduced protoporphyrin which is a rare co-factor, found only in cytochrome bd-type 
oxidases , cd1-type nitrite reductases and catalases (20).  
 Cytochrome bd is a two (or sometimes three) subunit transmembrane protein. The third 
subunit, cydX, is conserved in all most all proteobacteria, but appears to be absent in other 
organisms (12, 119, 120). Almost all the conserved amino acid residues found to be essential for 
catalysis, thus far, have been found in subunit I, cydA (23, 121) while subunit II, cydB and its 
rapid evolution has been associated with specific adaptations of bd in the presence of toxic 
compounds such as cyanide (122, 123). All the above co-factors have binding sites in subunit I 
though subunit II is found to be essential for the binding of hemes b595 and d (124). All of the 
insights into the catalytic mechanism of cytochrome bd have been obtained using evidence from 
biophysical and biochemical studies, particularly using the enzyme from Escherichia coli. The 
recently obtained crystal structure of cytochrome bd from Geobacillus stearothermophilus 
(unpublished data, courtesy of Schara Safarian from Max Planck Institute – Frankfurt) should help 
us make further strides in the elucidation of the mechanism of oxygen reduction. Another factor 
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that was delaying mechanistic study was the lack of a robust method for purification of cytochrome 
bd. The previous methods required several steps of purification but Hoeser et al. have recently 
prepared a construct that allows for purification of cytochrome bd in a single step using a strep tag 
(125). In this work, we characterize E. coli cytochrome bd using site-directed mutagenesis and, 
some biochemical and biophysical methods to understand its active site structure.  
 
 
Figure 4.1 Crystal structure of cytochrome bd from Geobacillus thermodenitrificans. E. coli 
numbering is used for residues. 
 49	
Active site structure 
 The residues binding low-spin heme b558 were found to be His186 and Met393 using site-
directed mutagenesis as well as NIR-MCD and EPR spectra (126-128). High spin heme b595 was 
shown to be bound to His19 (128, 129). The ligands to heme d have, however, remained in 
question. It was proposed that E99 could be a potential ligand to heme d but the recent crystal 
structure clearly refutes such a hypothesis (130, 131). In fact E445 is in close proximity to the Fe 
center of heme d, and could possibly be a ligand. (Figure 4.2) This is a flimsy hypothesisunlikely, 
however, since a previous mutation of E445 into alanine did not disturb heme d (132). 
Paradoxically, it damaged heme b595 instead. Similarly, a mutation of E99, a residue shown to be 
near to the Fe in heme b595 was shown to disturb heme d rather than heme b595 (130). All of this 
supports the idea that heme b595 and d are closely linked in their redox activity for which there is 
a lot of supporting evidence from spectroscopy, MCD and electrochemistry (17, 19, 133). 
Role of E445 in the catalytic mechanism of cytochrome bd 
 A mutation of E445 to alanine led to the perturbation of heme b595. Originally this was 
interpreted as the absence of heme b595 in the protein. Both the EPR spectrum of the oxidized 
protein and the absence of the bond between His19 and heme b595 from Resonance Raman spectra 
were interpreted as absence of the heme (132). However, a later study used CO-bound flash 
photolysis of E445A and EPR spectra of reduced protein conclude that the reduction of 
cytochrome bd had instead been disturbed by the mutation. A convincing model was proposed 
which hypothesized that two residues in the vicinity of the heme b595 and d were required to be 
protonated upon reduction and that E445 was one of these. E99 was possibly the other. In E445A, 
the presence of E99 allowed for the reduction of heme d but not, heme b595 (22). The crystal 
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structure indicates that E99 and E445 are far apart, dissuading us from the above hypothesis. A 
previous Resonance Raman spectrum had also shown that three carboxylate groups were 
protonated upon reduction (129). E107, E99 and E445 are some of the candidate protonatable 
carboxylate groups corresponding to this evidence. 
 
Figure 4.2 Binding sites of hemes d and b595 with E445 and E99 in close proximity, 
respectively. 
4.2 Results 
UV-visible spectra of E445 mutants 
Four mutations in the residue E445 were made using a Strep-tag construct previously 
prepared (125) – E445A, E445C, E445H and E445Q. Air-oxidized (Figure 4.3) and dithionite 
reduced (Figure 4.4) spectra of each of these mutants shows a diminished 595 nm and 440 nm 
signal which correspond to reduced heme b595. In addition, the mutant E445H also had a reduced 
heme d signal. There is a peak at 606 nm in the air oxidized spectra of E445A, whose origin is not 
yet understood. It has not been commented on before in literature. The reduced spectra also clearly 
 51	
reflect a lower absorbance of the peak at 560 nm but this is also explained by the perturbation of 
b595 since heme b595 does absorb at this wavelength. 
 
 
Figure 4.3 UV-visible spectra of wild type cytochrome bd and E445 mutants as prepared. The 
spectra were normalized to the peak at 412/413 nm and a baseline correction was applied. 
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Figure 4.4 UV-visible spectra of wild-type cytochrome bd and E445 mutants reduced by a few 
crystals of sodium dithionite. The spectra were normalized to the peak at 427/428 nm and a 
baseline correction was applied. 
 
The aberrant peak in the oxidized spectra of E445A is not oxygen-bound heme b595 
In the E445A mutant, the glutamate is replaced by alanine. This suggests that the oxygen 
has more room around the active site and could possibly diffuse past heme d and bind heme b595. 
In order to discount the possibility that the aberrant peak at 606 nm was oxygen-bound heme b595, 
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E445A was deoxygenated and an optical spectrum was obtained. However, it was found that the 
aberrant peak at 606 nm does not disappear upon deoxygenation. (Figure 4.54, Figure 4.65) 
 
 
Figure 4.5 Deoxygenation of WT cytochrome bd shows that the peak corresponding to the 
oxygen-bound heme is 646 nm. Air-oxidized protein is deoxygenated by repeated freeze-thaw 
cycles in the presence of Argon and then incubation in an anaerobic glove box. The protein is then 
reduced with Titanium dioxide. 
 54	
 
Figure 4.6 Deoxygenation of E445A shows that the peak corresponding to the oxygen-bound 
heme is 646 nm. Air-oxidized protein is deoxygenated by repeated freeze-thaw cycles in the 
presence of Argon and then incubation in an anaerobic glove box. The protein is then reduced with 
Titanium dioxide. The 606 nm peak does not disappear upon deoxygenation showing that it does 
not correspond to oxygen bound heme b595. 
A glutamine mutation in the place of E445 recovers oxygen reduction activity 
 The mutants E445A, E445C, E445H and E445Q were tested for oxygen reduction activity. 
Remarkably, E445Q was the only moderately active enzyme showing an oxygen reduction activity 
that was ~15% of WT bd. (Table 4.1) Previous evidence suggested that E445 played a role in 
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catalysis stabilizing the reduced heme d by being protonated upon reduction (22). Glutamine, in 
E445Q is not protonatable, suggesting that E445 may play a slightly different role or a more 
complex one than was previously believed. 
Sample 
Oxygen 
reduction 
activity 
(e-/s) 
% WT 
activity 
Oxygen 
reduction 
activity/heme b 
(e-/s) 
% WT 
activity 
%KCN 
inhibition 
WT bd 1466 ± 173 100.00 737±108 100.00 25.6 
E445A 12 ±2 0.85 9±2 1.24 94.5 
E445C 44 ±7 2.98 33±7 4.52 25.9 
E445H 19 ±2 1.32 19±3 2.63 37.4 
E445Q 218 ±11 14.87 84±6 11.48 25.6 
 
Table 4.1 Oxygen reduction activity of E445 mutants. 
 
A histidine mutation of E445 greatly perturbs the heme d binding site 
A heme analysis was performed on each of the mutants using pyridine hemochrome 
analysis and estimating the heme d content using the reduced minus oxidized spectra of each of 
the mutants. (Table 4.2) In E445H, heme d appears to be lost.  
Sample Heme b (µM) 
Heme d 
(µM) Heme b/Heme d 
WT bd 10.55 5.30 1.99 
E445A 49.00 35.89 1.37 
E445C 34.09 29.05 1.17 
E445H 8.43 - - 
E445Q 14.50 5.62 2.58 
 
Table 4.2 Heme analysis of E445 mutants using pyridine hemochrome spectral analysis. 
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Electrochemical analysis of hemes in E445 mutants 
 As previously noted, the reduction potential of hemes d and b595 have been shown to be 
inter-connected (19, 133). It would then be natural to expect that the midpoint potential of heme d 
would be affected by the drastic changes we can see to the heme b595 binding site. Yet surprisingly 
in E445A and E445C, the midpoint potential of heme d is only mildly affected with an increase or 
decrease of 20 mV respectively. In the E445Q however, the midpoint potential is significantly 
reduced, by about 50 mV. This can be explained by the replacement of E445 by Q, a residue that 
cannot be protonated. Histidine and Cysteine are also likely to be protonated but it is possible that 
the pKa in the context of the active site may vary.  
E445Q is the only one of the mutants for which the midpoint potential of heme b595 can be 
calculated as the reduction of heme b595 in E445C and E445A do not appear to be optically 
apparent. (Table 4.3) The midpoint potential of heme b595 has increased to 194 mV, indicating that 
some changes in the heme environment have made it easier to reduce. 
Surprisingly, the modification of E445 into Q has also drastically affected the midpoint 
potential of heme b558. Given the proximity of E445 to heme b558, it is possible that E445 affects 
the redox state of heme b558 and perhaps mediates electron transfer between heme b558 and heme 
d. 
Sample Heme b558 (mV) Heme d (mV) Heme b595 (mV) 
Detergent 
used 
WT bd 88.30 246.06 133.70 DDM 
E445A 46.90 265.59  DDM 
E445Q 183.00 199.16 194.00 DDM 
WT bd 183.00 289.00 134.00 SML 
E445C 156.00 222.65  SML 
Table 4.3 Midpoint potentials of hemes in WT cytochrome bd and E445 mutants. 
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4.3 Discussion 
 The crystal structure of cytochrome bd strongly supports a number of the theories 
previously suggested on the basis of biochemical evidence. The ligands of hemes b558 and b595 
have been verified and the residues that were expected to contribute to proton uptake (S140, E99, 
E107, H126) do appear to form a proton channel from the cytoplasm to periplasm.  
 Most interestingly the hemes d and b595 appear to be extremely close to one another (<3 Å) 
as the biochemical evidence had suggested. (Figure 4.7) However, heme b558 is also within electron 
transfer distance of both hemes d and b595 (~8 Å). Given the close proximity of all three hemes, it 
is likely that the proton transfer which stabilizes electron transfer is an integral factor to the electron 
transfer scheme. E445 is a protonatable residue very near to heme d. However, it also lies directly 
in the middle of heme b558 and heme d. (Figure 4.7)  
 
Figure 4.7 Tri-heme active site of cytochrome bd showing that the closest distance between 
heme b595 and d is 3.27 Å. The ring-to-ring distances between heme b558 and heme d, and heme 
b595 and d are 10.3	Å and 6.11 Å respectively. 
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 Our electrochemical evidence suggests strongly that the midpoint potential of heme b558 is 
affected by E445. This might indicate a role for E445 in the proton coupled electron transfer 
between heme b558 and heme d. E445 is said to be at around 3 Å from heme d and 6.95 Å from a 
propionate group of heme b558. If oxygen is bound to heme d, it is likely that E445 moves closer 
to heme b558, possibly making a hydrogen bond to heme b558. It is not clear in what way 
conformational changes or protonation state of E445 would affect heme b558, but it seems that it 
does affect its midpoint potential. Further experiments such as looking at the difference in 
protonation states between WT and E445 mutants using Resonance Raman and FTIR would be 
required to clarify these details. 
 
4.4 Materials and Methods 
Site directed mutagenesis of cytochrome bd oxidase from Escherichia coli 
The construct previously prepared for purification of WT cytochrome bd with a strep tag 
was used as a template (125). Mutagenesis primers were designed for point mutations at E445. 
(primer information in supplementary Table S1) The Quikchange mutagenesis kit (Stratagene) was 
used for PCR amplification. The plasmid with a mutation was transformed into XL-10 Gold cells 
and incubated overnight at 37 ℃	to recover colonies. The plasmid sequence was verified by 
submission for sequence verification with ACGT technologies. 
Cell Growth and Protein Purification 
A single colony was inoculated into 5 ml of LB (yeast extract and tryptone were purchased 
from Acumedia and NaCl from Sigma-Aldrich) with 100 µg/ml Ampicillin and incubated with 
shaking at 37 ℃. The following day, the 5 ml culture was inoculated in 300 ml LB with 100 µg/ml 
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Ampicillin and grown overnight at 37 ℃. On the third day, 10 ml of the secondary culture was 
inoculated into twenty four 2 L flasks containing 1 L LB with 100µg/ml Ampicillin, each. The 
flasks were incubated at 37 ℃ while shaking at 200 rpm, until the OD600 of the culture reached 
0.6. The temperature was then lowered to 30 ℃, and the culture was incubated for 8 hrs or 
overnight. 
The fully grown cultures were then pelleted by spinning down at 8000 rpm for 8 minutes, 
in 500 ml centrifuge bottles. The harvested cells were then resuspended in 100 mM Tris-HCl, 10 
mM MgS04, pH 8 with DNaseI and a protease inhibitor cocktail from Sigma. The cells were then 
homogenized using a Bamix Homogenizer, and passed through a Microfluidizer cell at 100 psi, 
three times, to lyse the cells. The soluble fraction of the lysate was then separated from the 
insoluble by spinning down the lysate at 8000 rpm. Membranes were extracted from the soluble 
fraction by centrifuging the soluble fraction at 42000 rpm for 4 hours.   
Membranes were resuspended in 50 mM sodium phosphate, 300 mM NaCl, pH 8 and then 
solubilized with 1% DDM or 1% SML. The solubilized membranes were spun down at 42000 rpm 
for 45 minutes to remove unsolubilized membranes. The supernatant was stirred with Strep-tactin 
resin (QIAGEN) for 1 hr and then loaded onto a column. The column was washed with 20 column 
volumes of 50 mM sodium phosphate, 300 mM NaCl, pH 8, 0.05% DDM. The protein was then 
eluted with 2.5 mM desthiobiotin in the above buffer. The fractions with protein were pooled in 
concentrated using an Amicon concentrator with a 100 kDa molecular weight filter. The 
concentrated protein was exchange in 50 mM sodium phosphate, 0.05% DDM, pH 7. This protein 
was used for further studies. 
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UV-visible spectroscopy 
Spectra of the protein were obtained using an Agilent DW-2000 Spectrophotometer in the 
UV-visible region. The cuvette used has a pathlength of 1 cm. The oxidized spectrum was taken 
of the air-oxidized protein. The enzyme was reduced with dithionite to obtain a reduced spectrum. 
Collection of Pyridine Hemochrome spectra and Heme Analysis 
For the wild type or mutant enzymes, 35 ul of the enzyme solution was mixed with an equal 
volume of 40% pyridine with 200 mM NaOH. The oxidized spectra were measure in the presence 
of ferricyanide and the reduced in the presence of dithionite. The values of heme b were calculated 
according to the matrix suggested in (116). The concentration of heme d was estimated using the 
extinction coefficient ε(629-670 nm) = 25 mM-1cm-1. 
Measurement of oxygen reductase activity 
Oxygen reductase activity was measured using the Mitocell Miniature Respirometer 
MT200A (Harvard Apparatus). 5 mM DTT and 250 µM Q1 were used as electron donors to 
measure oxygen reduction by the E445 mutants and wild type cytochrome bd. 300 µM KCN was 
used to test the cyanide sensitivity of the enzymes. 
Electrochemical measurement of midpoint potential of the hemes 
A potentiometer was connected to an Agilent DW-2000 Spectrophotometer to measure the 
solution potential and optical spectra simultaneously. A Calomel electrode is connected to a 
transparent cuvette and the electrode is then connected to a potentiometer. The cuvette contains a 
2.5 ml solution consisting of a cocktail of redox mediators, each at a final concentration of 10 µM 
and the protein. The solution is poised at a redox potential of 440 mV using potassium ferricyanide 
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and then successively reduced using a fresh sodium dithionite solution. At each successive 
reduction, an optical spectrum is obtained to monitor the reduction of the hemes optically.	The 
data was analyzed by fitting the data to the following function using OriginPro 2016 or 
Matlab R2015a.  
          y = 0)59/)((n
01
11101
A+A
Α−
+ −× mEX
  
The wavelength combinations used for the heme analysis were taken from which allowed for 
resolution of the individual optical spectra of the hemes (133). 
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4.5 Supplementary Information 
Table 4.4 Primers for preparation of E445 mutants 
Primer Tm Sequence 
Ecolibd_E445A-f 70.8 GGCTGGTTCGTGGCTGCGTATGGCCGCCAACCG 
Ecolibd_E445A-r 70.8 CGGTTGGCGGCCATACGCAGCCACGAACCAGCC 
Ecolibd_E445C-f 70.8 GGCTGGTTCGTGGCTTGCTATGGCCGCCAACCG 
Ecolibd_E445C-r 70.8 CGGTTGGCGGCCATAGCAAGCCACGAACCAGCC 
Ecolibd_E445H-f 70.8 GGCTGGTTCGTGGCTCATTATGGCCGCCAACCG 
Ecolibd_E445H-r 70.8 CGGTTGGCGGCCATAATGAGCCACGAACCAGCC 
Ecolibd_E445Q-f 70.8 GGCTGGTTCGTGGCTCAGTATGGCCGCCAACCG 
Ecolibd_E445Q-r 70.8 CGGTTGGCGGCCATACTGAGCCACGAACCAGCC 
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Chapter 5: Isolation and Characterization of a bb’-type oxygen reductase 
from Caldivirga maquilingensis 
5.1 Introduction 
 Archaea were the last domain of life to be discovered, following eukaryotes and bacteria 
(134). Archaea were originally found in extreme conditions of pH, temperature and salinity. 
Although they have since been discovered in more temperate habitats, it is clear that archaea have 
been the most successful of the three domains in adapting to harsh conditions. Since their 
discovery, scientists have been attempting to put newly discovered knowledge about Archaea, in 
the context of concepts established in the other two kingdoms of life. Archaeal transcription and 
translation machinery are similar to those of Eukaryotes, but like bacteria they are capable of many 
different kinds of metabolism (135-137). They are the only kingdom capable of methanogenesis 
and utilize many types of anaerobic respiration as well as aerobic respiration. While a number of 
respiratory complexes are homologous to those found in bacteria and eukaryotes, the adaptation 
of these proteins to the extreme niche of archaea is very important to consider.  
 Archaea have most of the proteins that constitute the aerobic respiratory chain of bacteria 
except complex I. Succinate-quinone oxidoreductases (138), cytochrome bc1 complexes (139) and 
heme-copper oxygen reductases from archaea have been characterized (140, 141). Cytochrome 
bd-type respiratory oxygen reductases are the other major family of terminal oxidases, besides the 
heme-copper oxygen reductase superfamily. The presence of cytochrome bd has been noted but 
no functional member of the cytochrome bd family in archaea has ever been established, according 
to the best of our knowledge (142-145). 
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 Cytochrome bd is an enzyme that converts oxygen to water using three hemes, unlike the 
HCO enzymes which use two hemes and copper. Cytochrome bd accepts electrons from quinols 
using a low-spin heme b558 and transfers these electrons to a di-heme active site containing two 
high spin hemes. In some of the characterized cytochrome bd enzymes, these active site hemes 
were shown to be one heme b and one heme d, but some other isoforms were shown to contain 
only hemes b. Those cytochrome bd family members that contain only hemes b were named the 
cyanide insensitive oxidase (CIO) or cytochrome bb’ oxidase, and have been identified in 
Pseudomonas aeruginosa, Bacillus subtilis and others. No CIO has ever been isolated and 
characterized. Cytochrome bd has been shown to have two subunits in many organisms, and three 
subunits in others. The function of this third subunit is still being investigated but it has been 
implicated in the stability of heme d and also in contributing to the activity of the enzyme. 
Cytochrome bd has been shown to generate proton motive force by translocation of protons from 
the cytoplasm to the periplasm. This has been hypothesized to occur using a conserved proton 
channel.   
 In this study we demonstrate the existence of a functional cytochrome bd-type oxidase in 
the archaeon, Caldivirga maquilingensis. Caldivirga maquilingensis is the only identified member 
of the genus Caldivirga, belonging to family Thermoproteaceae, of the order Thermoproteales. 
Caldivirga maquilingensis was isolated from a hot spring in Phillipines, and grows optimally at 
85 ℃  and at a pH between 3.7-4.2. We show that the isolated enzyme is highly thermostable, 
consistent with origin in a hyperthermophile. This bd family member is also shown to be a cyanide 
insensitive oxidase (CIO) containing only hemes b. Its unique biochemical and structural 
characteristics are discussed, including its novel subunit II, which is homologous to subunit I. This 
archaeal cytochrome bb’ is widely distributed in archaea, including several organisms previously 
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thought to be strictly anaerobic. We believe that the metabolic adaptations of archaea and their 
aerobic respiratory chains need to be reconsidered in the context of existing and functional 
cytochrome bb’ oxygen reductases.  
Distribution of cytochrome bd-type oxygen reductases 
 Cytochrome bd-type oxygen reductases have been found in bacteria and archaea. A 
genomic analysis of the cytochrome-bd type oxygen reductases reveal many different phylogenetic 
groups of the enzyme. (Figure 5.1)  
 
Figure 5.1 Cytochrome bd-type oxygen reductase superfamily representing the different 
phylogenetic groups. 
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 Distinct families of the enzyme were revealed including a family of enzymes prominently 
present in the Bacillus clade, a family of enzymes in Archaea and a most unique family in sulfate 
reducers such as Shewanella which have an enzyme that appears to have the oxygen reduction site 
conserved but, attached to a cyt c binding site instead of a quinol binding site. (Supplementary 
Figure S1) The Bacilli enzymes appear to have some distinct features in the active site. The 
enzymes unique to archaea have a subunit II that seems to be structurally related to subunit I rather 
than the other subunits II. In fact, a close look at the crystal structure from Geobacillus 
thermodenitrificans (refer Chapter 4, Figure 4.1) shows some similarity between the subunits I and 
II of the bd. A further study of these factors in the evolution of this enzyme superfamily would be 
needed for us to better understand these observations. The purification of an enzyme from Archaea 
and with the crystal structure, our ability to make assessments of the importance of subunit II 
would help us begin that investigation.  
5.2 Results  
Purification and spectroscopic characterization of the bb’ from C. maquilingensis 
 Cytochrome bb’ from Caldivirga maquilingensis consisted of two genes – cydA and cydB. 
The protein encoded by cydA was homologous to subunit I of Escherichia coli cytochrome bd. As 
previously mentioned, the product of cydB is also homologous to subunit I. The operon was cloned 
into the pET22b vector and expressed in an Escherichia coli strain, CBO (C43, ΔcydA ΔappB) 
(125). Escherichia coli has two cytochrome bd –type oxygen reductases encoded in the genome; 
CBO has both knocked out. The enzyme from Caldivirga were engineered to have numerous 
different tags – 6xHistidine, FLAG, GST and GFP. None of the above tags were successful, either 
because of a poor yield of protein or because of the inability of the affinity-tagged proteins to bind 
to columns with their corresponding epitopes. A GFP-tagged protein was used to verify the 
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expression of cytochrome bb’-type oxygen reductase from Caldivirga maquilingensis. The 
presence of the protein could be noted by following the fluorescence of the protein under UV light. 
The purified protein was verified by mass spectrometry. Subunit I from Caldivirga maquilingensis 
bb’ was revealed in the mass spectrum. (Supplementary Figure S3) 
 A reduced-minus-oxidized spectrum of bb’ reveals the absence of the heme d absorbance 
peak. The presence of heme b595 is also not apparent in the spectrum; there is no maxima at 595 
nm and the soret peak at 440 nm is also missing. (Figure 5.2) 
 
Figure 5.2 UV-visible spectra of cytochrome bd from Escherichia coli and bb’ from Caldivirga 
maquilingensis. 
 Pyridine hemochrome spectra of bb’ 
 Hemes were extracted from cytochrome bb’ of Caldivirga maquilingensis as described 
previously (116). It was clearly shown that the only kind of hemes in the protein were b-type 
hemes. (Figure 5.3) This was verified by analyzing the hemes in the protein by LC-MS. (data not 
shown)  
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Figure 5.3 Pyridine hemochrome spectra of Escherichia coli bd and Caldivirga 
maquilingensis bb’. 
Oxygen reduction activity of cytochrome bb’ and cyanide insensitivity 
 The oxygen reduction activity of cytochrome bb’ was tested using a clark electrode, with 
reduced coenzyme Q1 (reduced using DTT) as the electron donor. (Table 5.1) At 37 ℃ the activity 
is ~330 e-/s (/heme b). While this is not as high as the activity of E. coli bd at the same temperature 
(over 1000 e-/s), the enzymatic activity is still significant, particularly considering the fact that the 
source of the enzyme is a thermophilic organism whose growth is optimum at 65 ℃. The oxygen 
reductase activity of cytochrome bb’ was also cyanide insensitive, at 150-250 µM KCN, a 
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concentration of cyanide that would inhibit the activity of heme-copper oxygen reductases (23). 
This is a characteristic feature of cytochrome bd-type oxygen reductases, and is a characteristic 
that does not appear to be affected by the absence of heme d. The enzyme is also susceptible to 
Aurachin AC1-10, a known inhibitor of cytochrome bd at concentrations as low as 250 nM (146). 
(Supplementary Figure S2) 
Sample Oxygen reduction activity (e-/s) 
Escherichia coli bd 333 ± 20 
Caldivirga maquilingensis bb’ 1065 ± 73 
Table 5.1 Oxygen reduction activity of cytochrome bd and cytochrome bb’ in the presence of 
350 µM coenzyme Q1 and 5 mM DTT. 
Structural model of cytochrome bb’ oxygen reductase from Caldivirga maquilingensis 
 A structural model of cytochrome bb’ was created using the Swiss PDB server. In 
accordance with the similarity and high degree of conservation between the subunits I from 
different organisms, the model of subunit I was easily obtained. Subunit II of cytochrome bb’ could 
only be modelled by using subunit I as a template, a result in agreement with the closer similarity 
of subunit II from bb’ with the well-conserved subunit I. A closer look at the active site of 
Caldivirga maquilingensis reveals that a highly conserved W441 has been substituted by Alanine. 
This substitution has occurred a number of times in Thermoproteales. Comparing the active sites 
of Caldivirga maquilingensis and Geobacillus thermodenitrificans also shows us that a few charge 
residues around the heme d binding sites are missing. E371 and Y375 are replaced by I388 and 
V392. Sequence analysis of all the active sites in cytochrome bd-type oxygen reductases reveal 
that the residues near the heme d- binding site in a majority of the enzymes from proteobacteria 
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around the well-conserved GWxxxExGRxPW site are polar. In archaea and some Bacilli, residues 
are replaced by hydrophobic residues. The effect of this change in the active site may have on the 
function of the enzyme is not obvious and must be further investigated. 
 
Figure 5.4 Structural model of subunits I from Geobacillus thermodenitrificans and 
Caldivirga maquilingensis respectively. The boxed regions reveal more polar residues in 
Geobacillus, colored by red. Green represents aromatic residues. 
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Similarity between subunit I and subunit II 
A close look at subunit II of bb’ from Caldivirga maquilingensis reveals that subunit II is 
structurally similar to subunit I. The first four helices of subunit II, which form the oxygen 
reduction site, are similar to the first four helices of CydA, the canonical subunit I of cytochrome 
bd-type quinol oxidase. (Figure 5.5) The features constituting the binding site of heme b558 and the 
quinol binding site are conspicuously absent. This unique form of subunit II is present only in 
archaea.  
 
 Figure 5.5 Subunit I of bb’ from Caldivirga maquilingensis is represented by a scheme of TM 
helices. Subunit II, is represented as cydA- homolog, a modified version of subunit I.  
 
A phylogenetic analysis of subunits II and subunits I reveals that these subunits II cluster separately 
and seem to be related to a modified subunit I present in Rubrococcus sp.  (Figure 5.6) It is not 
possible to make conclusions about the evolutionary history of this unique subunit II based on this 
phylogenetic analysis. Further understanding of the role of subunit II would be useful towards this 
end.  
 
TMH1 TMH2 TMH3  TMH4 TMH5 TMH6 TMH7 TMH8 TMH9 
TMH1 TMH2 TMH3  TMH4 TMH5 TMH6 TMH7 TMH8 
cydA 
cydA - homolog 
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Figure 5.6 Phylogenetic tree of cydA and cydA-homologs showing that they cluster 
separately. cydA-homologs are more closely related to a modified subunit I present in 
actinobacteria. 
 
5.3 Discussion 
 The presence of cyanide insensitive oxidases containing only hemes b has been reported 
previously in literature but no active bd-type enzyme has ever been purified with only b-type 
hemes. In this work, we have demonstrated the purification of an active enzyme from Caldivirga 
maquilingensis which contains only b-type hemes. This demonstration eliminates the possibility 
cydA 
cydA-homolog 
Modified subunit I from 
actinobacteria 
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that in the previous studies in membranes, the d heme signal may have been masked because of 
the enzymes’ low abundance in membranes.  
 Observation of the in-situ conversion of b-type heme into d-type heme in Catalase II (147, 
148) from Escherichia coli has led to speculation that a similar reaction is responsible for the 
conversion of heme b to heme d in the active site of bb’-type enzymes. Further investigation of the 
active site in bb’ from Caldivirga may lead to answers for that question. Our structural models of 
the enzyme reveal that there are fewer polar residues in the heme d binding site of Caldivirga. 
Whether this affects the function and properties of the enzyme would also need to be tested.  
 Finally, we have shown for the first time that a cytochrome bb’-type oxygen reductase 
encoded for in archaea is active. The presence of these enzymes in a number of archaea 
specializing in surviving in hypoxic environments (142) suggests that the enzyme might be pivotal 
in the adaptation of these archaea to hypoxic habitats.  
 
5.4 Materials and Methods 
Preparation of construct for of cytochrome bd oxidase from Escherichia coli 
 The genes encoding the bb’ oxygen reductase (Gene Object ID: 641276193-4) from C. 
maquilengensis were PCR amplified using primers purchased from Integrated DNA Technology. 
The genes were cloned into pET22b (Invitrogen) using 5’ NdeI and 3’ XhoI cut sites. The inherent 
6-Histidine tag in the vector was used to purify the protein. The vector was engineered to use 
EGFP, GST or FLAG tags alternatively. The tag was added to subunit II in case of EGFP and 
FLAG; a tag on both subunit I and II was attempted for the His-tag and GST tag. The expression 
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vector, along with pRARE (Novagen) was then transformed into (CBO ΔcydBΔappC::kan) for 
protein expression. 
Cell Growth and Protein Purification 
 A single colony was inoculated into 5 ml of LB (yeast extract and tryptone were purchased 
from Acumedia and NaCl from Sigma-Aldrich) with 100 µg/ml Ampicillin and incubated with 
shaking at 37 ℃. The following day, the 5 ml culture was inoculated in 300 ml LB with 100 µg/ml 
Ampicillin and grown overnight at 37 ℃. On the third day, 10 ml of the secondary culture was 
inoculated into twenty four of 2L flasks containing 1 L LB with 100 µg/ml Ampicillin, each. The 
flasks were incubated at 37 ℃ while shaking at 200 rpm, until the OD600 of the culture reached 
0.6. The temperature was then lowered to 30 ℃, and the culture was incubated for 8 hrs or 
overnight. 
 The fully grown cultures were then pelleted by spinning down at 8000 rpm for 8 minutes, 
in 500 ml centrifuge bottles. The harvested cells were then resuspended in 100 mM Tris-HCl, 10 
mM MgS04, pH 8 with DNaseI and a protease inhibitor cocktail from Sigma. The cells were then 
homogenized using a Bamix Homogenizer, and passed through a Microfluidizer cell at 100 psi, 
three times, to lyse the cells. The soluble fraction of the lysate was then separated from the 
insoluble by spinning down the lysate at 8000 rpm. Membranes were extracted from the soluble 
fraction by centrifuging the soluble fraction at 42000 rpm for 4 hours.   
 Membranes were resuspended in 20 mM Tris, 300 mM NaCl, pH 8 and then solubilized 
with 1% DDM or 1% SML. The solubilized membranes were spun down at 42000 rpm for 45 
minutes to remove unsolubilized membranes. The supernatant was stirred with Ni-NTA resin for 
1 hr and then loaded onto a column. The flow through was shown to contain the bb’ because of its 
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poor affinity for the nickel column. The flow through was then diluted in buffer to contain 50 mM 
salt and then loaded onto a DEAE column equilibriated with 20 mM Tris, pH 8, 0.05% DDM. An 
elution gradient was run between 0-500 mM NaCl and bb’ was partially purified and used for 
assays and spectroscopy. 
UV-visible spectroscopy 
 Spectra of the protein were obtained using an Agilent DW-2000 Spectrophotometer in the 
UV-visible region. The cuvette used has a pathlength of 1cm. The oxidized spectrum was taken of 
the air-oxidized protein. The enzyme was reduced with dithionite to obtain a reduced spectrum. 
Collection of Pyridine Hemochrome spectra and Heme Analysis 
 For the wildtype or mutants enzymes, 35 µl of the enzyme solution was mixed with an 
equal volume of 40% pyridine with 200 mM NaOH. The oxidized spectra was measure in the 
presence of ferricyanide and the reduced in the presence of dithionite. The values of heme b were 
calculated according to the matrix suggested in (116). The concentration of heme d was estimated 
using the extinction coefficient ε(629-670nm) = 25 mM-1cm-1. 
Measurement of oxygen reductase activity 
 Oxygen reductase activity was measured using the Mitocell Miniature Respirometer 
MT200A (Harvard Apparatus). 5 mM DTT and 350 µM Q1 were used as electron donors to 
measure oxygen reduction by the E445 mutants and wildtype cytochrome bd. 150-250 µM KCN 
was used to test the cyanide sensitivity of the enzymes. 
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Structural modelling of cytochrome bb’ from Caldivirga maquilingensis 
 Sequences of subunit I from Geobacillus thermodenitrificans and Caldivirga 
maquilingensis were aligned using a larger alignment comprising many hundreds of bb’ sequences 
made with the software MUSCLE. This alignment was used as to create a model of subunit I from 
Caldivirga using the Geobacillus subunit I as a template on the Swiss Model server. A model of 
subunit II was also created using subunit I as a template. (The alignments are provided as 
Supplementary Figures S4 and S5) The model was then visualized using VMD 1.9.2beta1. 
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5.5 Supplementary information 
Figure 5.7. Alignments of the S-family cytochrome bd with other bd-type oxygen reductases 
reveals the presence of the motif CxxCH, which binds cytochrome c.  
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Figure 5.8 Cyanide-insensitive oxygen reduction activity of cytochrome bb’. 
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Figure 5.9 Mass spectrometric verification of subunit I from Caldivirga cytochrome bd. 
Protein sequence coverage: 12% 
  Matched peptides shown in bold red. 
1 MPSAYVLSII NASTLDAARW VSAIGILAHL SLASSFLGTI LIAVIAEYLY 
51 LVKHDKDWYD KARMFSVVST IFFGVGAAFG TLVEFGLVTI WSNFITIIGS 
101 AIVLPFYLEL FAFLTEVILL PLYVFTWGKV RNGWVHWVIG LAAAFGGYWS 
151 AYNILAVMAS LSMRPPGMII QNLAASNETI AGLTSYLVTW AKPTDAWNMF 
201 WWGANVFIFH GILAAAILTW SVVGAIYLYG YVREHRPDQA KVLKVIIPGV 
251 AVMTAIEGFI LGHDQGELVL QFDPLKLAAI EGMFWKGLKV DPLLSFFAYG 
301 TFNHAFWGYY SWPANVRPPL APFDFLPIFY LGFMVTLGVL LGVWSGGLSL 
351 WYLFNGFFSR FNWARVIASF LERTGPYAMP LFAALAAIGG AVTSESGRVP 
401 FILVDSSPNP NGGPPTVTGV PIYEGGLINP NLSLPGWLVA LIIIVEVAMP 
451 ALAVYMVYLY TKPKEVKPTQ VVEY   
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Figure 5.10 Alignment of subunits I from Geobacillus and Caldivirga. 
641276194         2      PSAYVLSII NASTLDAARW VSAIGILAHL SLASSFLGTI LIAVIAEYLY 
cm1s              1      MNGYDPVLL -------SRI LTELTLTVHI IYATIGVGVP LMIAIAQWVG 
                    ..*   ..        .*  .. . .  *.   *.  .*   *.  **. .  
 
641276194         51    LVKHDKDWYD KARMFSVVST IFFGVGAAFG TLVEFGLVTI WSNFITIIGS 
cm1s              43    IRKNDMHYIL LARRWTRGFV ITVAVGVVTG TAIGLQLSLL WPNFMQLAGQ 
                      . *.*.      **  .     *  .**   * * . . *  . *.**. . *  
 
641276194         101   AIVLPFYLEL FAFLTEVILL PLYVFTWGKV RNGWVHWVIG LAAAFGGYWS 
cm1s              93    VISLPLFMET FAFFFEAIFL GIYLYTWDRF ENQKKHLLLL IPVAIGSSAS 
                         * **...*  ***. * *.*  .*..** .   *   * ..  .. *.*.  * 
 
641276194         151   AYNILAVMAS LSMRPPGMII QNLAASNETI AGLTSYLVTW AKPTDAWNMF 
cm1s              143   AMFITMVNAF MNTPQG-FEL KNGE-----L VNIDPI---- ------VAMF 
                        *  *  * *  ..       .  *       .   . .              ** 
 
641276194         201   WWGANVFIFH GILAAAILTW SVVGAIYLYG YVREHRP--- -DQAKVLKVI 
cm1s              177   NPAMPTKVAH VLATSYMTSA FVLASIAAWH LWKG---NRH I-YHRKALHL 
                          .    . *  . .. . .   *...*       .            .    . 
 
641276194         247   IPGVAVMTAI EGFILGHDQG ELVLQFDPLK LAAIEGMFWK GLKV--DPLL 
cm1s              223   TMKTAFIFSV ASALVGDLSG KFLAEYQPEK LAAAEWHFE- TSSHAPLILF 
                            * . ..  . ..*   *  .. ...* * *** *  *           *. 
 
641276194         295   SFFAYGT-FN ---------H AFWGY----- --------YS WPANV-RPPL 
cm1s              272   GTL-EEDNEV KYALEIPYAL SILAHNHPAA VVTGLNDI-- PED--ERP-- 
                        . .                   .. .                        **   
 
641276194         321   APFDFLPIFY LGFMVTLGVL LGVWSGGLSL WY-LFNGFFS RFNW------ 
cm1s              315   ---PLYIHYL FDVMVTIGVF LMVVAAVYWL GSI------- ---FRWKWTA 
                            .   .  .  ***.**. * * ..   *                       
 
641276194         364   -ARVIASFLE RTGPYAMPLF AALAAIGGAV TSESGRVPFI LVDSSPNPNG 
cm1s              352   K------NWF FGLLVAGGPL AMIAIEAGWY LAEVGRQPWI L--------- 
                                        *   . * .*  .*    .* ** * * *          
 
641276194         413   GPPTVTGVPI YEGGLINPNL SLPGWLVALI IIVEVAMPAL AVYMVYLY   
cm1s              387   ----RGYMKT AEGATTSAHV DTMLVLFCLL YIVLVIASAT VLIRMFRRNP 
                               .    **.  ....      *  *.  ** *  .*   .  ..     
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Figure 5.11 Alignment between subunit II of Caldivirga and subunit I from Geobacillus. 
 
641276193         1       MVSPVVAT VALIAWAFSV HLPLVYTVLG LG--WLLPTL ELLGYRSGRR 
cm1s              1       MNGYDPVL LSRILTELTL TVHIIYATIG VGVPLMIAIA QWVGIRKNDM 
                          * .      .. *   ...  . ..*. .* .*   ...   . .* *     
 
641276193         47    TYIDIAHGLS SYLIAVYAIG GVFGTIVTVF LAGLLPVFTN IAGALLWPVW 
cm1s              49    HYILLARRWT RGFVITVAVG VVTGTAIGLQ LSLLWPNFMQ LAGQVISLPL 
                         ** .*.  .   ..   *.*  * ** . .  *. * * *   .** ..     
 
641276193         97    GIAIVFGVAI ALPLIGFYYR SFNRLS-PMR HVAVGYGMAI TLTVIPVMFR 
cm1s              99    FMET-FAFFF EAIFLGIYLY TWDRFENQKK HLLLLI-PVA IGSSASAMFI 
                         .   *.  .    ..*.*   . .*.   .. *. .         .  . **  
 
641276193         146   LVF-AFINYP AGVAIAPSST SNTGFTLSVN LTEALSNPTY PPLLLATLFG 
cm1s              147   TMVNAFMNTP QGFEL----- -KNGELVNID PIVAMFNPAM PTKVAHVLAT 
                         .  **.* *  *  .       . *  ....    *. **.  *  .   *   
 
641276193         195   AIAMTSILVS SIHGWRYASS -RSEYHELGH RIGNTVGLIF GILYSIFAAW 
cm1s              191   SYMTSAFVLA SIAAWHLWKG NRHIYHRKAL HLTMKTAFIF SVASALVGDL 
                        .   ...... ** .*.   .  *  **  .  ..    ..** ..  .. .   
 
641276193         244   YLYTVYQYSP -------T-- ------VAWS IFG------- -----HPPSY 
cm1s              241   SGKFLAEYQP EKLAAAE-WH FETSSHAPLI LFGTLEEDNE VKYALEIPYA 
                            . .* *                   .   .**               *   
 
641276193         267   L--------P SAFYGLYK-- ----PTFNLS WMLYMNIALG AVILILLVVS 
cm1s              290   LSILAHNHPA AVVTGLNDIP EDERPPLYIH YLFDVMVTIG VFLMVVA-AV 
                        *        . .   **         * . .   .. . ...*   ....     
 
641276193         303   IKVTSKPIE- --------VL KLIL--TPML MDSAEV---M NGLAHVPYAI 
cm1s              339   YW--LGSIFR WKWTAKNWFF GLLVAGGPLA MIAIEAGWYL AEVGRQPWIL 
                              .*            .  *..   *.  * . *    .   ... *  . 
 
641276193         339   VPPVAAAEAL IKAYGLSFAL NVAKWLTI-S QLLTPQINAL LSLVSVQP   
cm1s              387   RGYMKTAEGA TT--SAHVDT MLVLFCLLYI VLVIASATVL IRMFRRNP   
                           . .**.      .       .     .    *. .    * . .    *   
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